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ABSTRACT 
This was a cross-sectional descriptive investigation 
designed to describe the symptoms reported by women in the 
perimenopausal transition. Seventy-eight women completed 
a 2-part questionnaire concerning their experiences with 
menopause. The first part contained an open-ended 
question asking the women to list symptoms that they 
attributed to menopause. The second portion contained a 
checklist of menopausal symptoms adapted from the Blatt 
Menopausal Index and was administered after the women had 
returned the open-ended section. Severity of symptoms was 
assessed on both portions of the questionnaire. Analysis 
of the open-ended questionnaires revealed 45 different 
symptoms. The 6 most frequently reported symptoms on the 
open-ended questionnaire were found on the checklist 
portion, as well. A significantly larger number of 
symptoms were reported on the checklist and women who used 
hormones or vasoactive drugs rated their symptoms as more 
severe. Demographic data and lifestyle characteristics 
were analyzed; however, it was found that lifestyle traits 
did not affect the women's perceptions of menopausal 
experiences. 
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CHAPTER I 
INTRODUCTION AND REVIEW OF 
LITERATURE 
Introduction 
Menopause has been defined as a point in a woman's 
reproductive years when she ceases to have menstrual 
cycles. The onset of menopause is marked by changes in 
female hormones. These changes are often heralded by hot 
flashes or irregular periods, and some women report 
symptoms lasting from 1 to 10 years (Caldwell, 1982). 
Such changes precede and continue after the cessation of 
the last menstrual flow. During the transitional years, 
called the menopausal transition, many physiological 
adjustments are made in resposne to the declining amounts 
of gonadotrophic and/or gonadal (estrogen) hormones. 
Hence, the term perimenopausal transition has been 
suggested as a preferable term to explain the process of 
physiological change occurring in women (Greene, 1980; 
Pearson, 1980; Reitz, 1977; Voda, 1981). 
Concurrent with these physiological changes, the 
women of this age group often experience lifestyle 
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changes. The changes may include increased responsibili-
ties for the woman's parents (who are now elderly and may 
be in need of care) along with the maturation of the 
woman's children and their leaving home. Many authors 
feel that such events may also influence the impact of the 
perimenopausal transition (Milletti & Hawkins, 1983; 
Neugarten & Kraines, 1965; Pearson, 1982; Reitz, 1977). 
The onset of the perimenopausal transition is 
reported to vary from age 40-55 (Ballinger, Cobbin, 
Krivanek & Saunders, 1979; Voda, 1984). This coincides 
with a documented "life change" of men. The spouse of the 
menopausal woman mayor may not be experiencing a concur-
rent life crisis. If so, this could also have an impact 
on the perimenopausal change for the woman (Ballinger et 
al., 1979). Women without male partners also may be 
influenced by the changes in the lives of those around 
them, although there is no documentation for this. 
The response to such biochemical, physiological and 
psychosocial adjustments is often noted by women in the 
form of unusual somatic, psychic and social symptoms. In 
addition to irregular or absent menstruation, other 
physiological symptoms have been identified. These 
include hot flashes, drying of vaginal mucosa, headaches, 
dizziness, lack of concentration, irritability, loss of 
libido, joint pains, apathy, lassitude, muscular weakness, 
and palpitations (Dewhurst, 1976). In spite of the 
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enumeration of a variety of symptoms many authors have 
continued to focus only on menstrual irregularities and 
the hot flash (Er1ik, Meldrum & Judd, 1982; Pearson, 1982; 
Voda, 1984). 
Questions remain unanswered regarding which body 
symptoms are a normal accompaniment of the menopausal 
adjustment period. This is due, in part, to a lack of 
knowledge regarding what women are experiencing during the 
perimenopausa1 transition. The questions asked most 
frequently by women who are experiencing menopause are: 
How long are my hot flashes going to last? How 
long do I need to use birth control? What kind 
is safest? Will I lose my mind? What is your 
opinion of "hormones?" How can I have a healthy 
menopause? What am I to do about uncomfortable 
intercourse? (Caldwell, 1982, pp. 1100-1101). 
Historically, physicians have used their own exper-
iences with women in nonresearch clinical settings as the 
criterion for treatment of other female patients during 
the menopause. The result has been confusion for women 
and the medical community alike (Pearson, 1982). Many 
researchers have addressed themselves to the lack of 
studies of symptoms of the perimenopause (Blatt, Weisbader 
& Kupperman, 1953; Delaplaine, Bottomy, Blatt, Weisbader 
& Kupperman, 1952; Kupperman, Blatt, Weisbader & Togashi, 
1952). Different populations have been surveyed using a 
variety of instruments and research techniques. One of 
the noteworthy deficits among the menopausal research is 
the lack of studies of women who were drawn from non-
who experienced no symptoms of the perimenopause (Bal-
linger et al., 1979). 
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One of the first studies examined the menopause using 
the Blatt Menopausal Index (BMI). The BMI has become a 
standard in the field of menopausal studies and is often 
cited (Delaplaine et al., 1952). This index has been 
used, modified, changed, and reused as a "classical" 
measurement in most studies. The question arises, 
however: Is a listing of symptoms as used in the Blatt 
Menopausal Index or similar questionnaires an appropriate 
measure of the nonclinical, perimenopausal experience? 
Purpose of the study 
The purpose of this study was to investigate and 
describe the symptoms of the menopausal transition as 
experienced and reported by at least 50 women in a 
nonclinical setting who were in menopausal transition. 
Review of Literature 
This section on review of the literature will include 
several major subject headings. These topics are: (a) 
terminology of menopause, (b) physiological changes of 
menopause, (c) symptoms of menopause, (d) specific factors 
which influence a woman's perception of menopausal 
symptoms, and (e) specific factors that relieve, postpone 
or mask menopausal changes. The latter two subject areas 
will be subdivided to address those specific factors 
thought to influence perception and change the timing or 
symptoms of menopause. 
Terminology of the Menopause 
One of the confusing elements of this transition 
period is the multiplicity of terms used. For example, 
menopause, menopausal transition, perimenopausal transi-
tion and climacteric are often used synonymously to 
describe this transitional period. Coope (1975) stated 
that menopause has been hard to define throughout modern 
history. 
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Neugarten and Kraines define menopause as "the 
cessation of menses" (1965, p. 66) and the climacterium as 
"the involution of the ovaries and the various processes 
associated with this involution including menopause" 
(Neugarten & Kraines, 1965, p. 266). Likewise, Seaman and 
Seaman (1977) state that menopause is the point where 
menses cease, and climacteric a period of time of approxi-
mately 15 years wherein a woman experiences widespread 
tissue changes. Greene (1980), however, uses the term 
climacterium to cover all the transition period including 
involution of the ovaries and both pathological and normal 
hormonal changes. 
Other means have been used to describe this transi-
tion. For example, Gregory (1982) divides the process 
into three phases. The first phase is described as 
"premenopausal," the time when a woman experiences many 
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"premenopausal," the time when a woman experiences many 
anovulatory cycles, irregular menses with a decline of 
premordial follicles, a low sensitivity of the ovary 
follicle to gonadotrophins and decreased estrogen produc-
tion in the ovaries. The second phase is menopause 
itself, described as the last menstrual flow, which is the 
direct result of too little circulating estrogen. The 
final phase, the postmenopausal period, is described as a 
cessation of menses with decrease in circulating estrogen, 
androstenedione, and testosterone. 
Likewise, Greene (1980) identifies four phases of 
this change of life as the premenopausal, transitional, 
menopausal, and postmenopausal phases. Women having had 
menses regularly with no change in volume over the last 
year and having menstruated in the last 3 months are 
called premenopausal. Transitional women have had menses 
in the last 3 months, but report a change in regularity or 
volume during the preceding 12 months. Those women who 
had no menses in the last 3 to 12 months are identified as 
being menopausal. The group defined as postmenopausal 
have had no menstruation in the last 12 months. 
Moaz and Durst (1980) and Erlik, Meldrum and Judd 
(1982) used the criterion of 6 months since the last 
menstrual period in order to define a woman as postmeno-
pausal. utian (1980) defined menopause as the last 
menstrual period and discussed the events of premenopausal 
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and perimenopausal hormone content. He also recognized 
various stages within the menopausal transition. 
Groups of investigators have worked together to 
clarify the terminology of the menopause (Utian & Serr, 
1976). The First International Congress on Menopause 
agreed that 
... the climacteric is that phase in the aging 
process of women marking the transition from the 
reproductive stage of life to the nonreproduc-
tive stage (Utian & Serr, 1976, p. 1). 
Menopause was defined by this group as the last menstrual 
period a woman experiences. 
In 1981, the World Health Organization recognized the 
confusion in the medical literature regarding the utiliza-
tion of multiple terms to describe the menopause. They 
agreed on the following: 
1. That the term menopause be defined as the 
permanent cessation of menstruation resulting 
from loss of ovarian follicular activity; 
2. That the term perimenopause or climacteric 
be used to include the period immediately prior 
to the menopause ... and at least the first year 
after the menopause; 
3. That the postmenopause be defined as dating 
from the menopause, although it cannot be 
determined until after a period of 12 months of 
spontaneous amenorrhea has been observed ... 
premenopause ... to refer to the whole of the 
reproductive group prior to the menopause (WHO, 
1981). 
To summarize, a significant lack of consensus abounds in 
the research literature concerning the definition of terms 
surrounding the menopause. This situation often leaves 
the reader confused as to the exact definition of the 
perimenopause used by specific authors. In this study, 
the author has used the definitions cited previously in 
this work as generated by the WHO (1981). 
Physiological Changes of the 
Menopause 
The second area of confusion is related to the 
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symptoms women experience at this time. Many authors note 
the wide variety of experiences women and their clinicians 
report occurring during the menopause. Reasons for these 
changes have been explained, in part, by the physiology of 
the menopause. The most widely accepted model of events 
of the perimenopausal period are explained within the 
scientific paradigm of hypothalamic/anterior pituitary/go-
nadal axis model (Lauritzen, 1975). 
The two main physiological changes that have been 
found to occur in women during the perimenopause are 
first, lowered levels of estrogen, and second, an eleva-
tion of the serum gonadotrophins follicle-stimulating 
hormone (FSH) and the luteinizing hormone (LH) (Jones & 
Wentz, 1982). It has been found, however, that these 
levels fluctate widely during the perimenopausal period 
(Jones & Wentz, 1982). This fluctuation has also been 
noted by Sherman, West and Korenman (1976) in their 
studies of LH and FSH in menopausal women. Further 
obscuring the fluctuation of gonadotrophins is the ability 
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of the ovarian stroma cells and adrenal gland to produce 
androstenedione, which can be converted in "the skin and 
appendages to estrone" (Jones & Jones, 1981, p. 797). In 
essence, circulating levels of these hormones can vary 
greatly from woman to woman. In addition, the differences 
in symptoms women have reported during the perimenopausal 
period compound attempts to clarify the relationships 
between symptoms and physiological changes. 
It is important to also consider those women who have 
entered the climacteric by other than the usual physio-
logic means and those who take hormone preparations to 
delay or modify symptoms of the perimenopause. Some women 
may have had surgical removal of the ovaries and uterus, 
or have had these organs rendered less effective or 
completely ineffective by radiation and/or chemical 
interventions. Women who take hormones also have altered 
experiences in the perimenopausal transition. It has been 
proposed that these groups of women experience the 
perimenopausal transition differently than those who enter 
the climacteric more gradually and "naturally" (Adena & 
Gallagher, 1982). 
The perimenopausal transition is not influenced 
solely by physiological events, but is a complex process. 
utian (1980, p. 106) states concisely that: 
While further clarification is necessary, the 
International classification does help clear up 
the confusion. The definitive statement is made 
that the varied symptom profile after menopause 
is caused by an interaction between three 
components: 
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(1) decreased ovarian activity with altered 
hormone profiles; 
(2) social, cultural and environmental 
factors; and 
(3) psychological factors (Utian, 1980, p. 
106) . 
Symptoms of the Menopause 
Perhaps the work by Delaplaine et al. (1952) serves 
as the best example of the classical picture of the 
symptom complex of the menopause. The authors introduce 
a "menopausal index" to describe the typical symptoma-
tology. In order to understand how this index originated 
and was later adapted, the work of Delaplaine et al. will 
be described in detail. 
According to these authors, the index was a config-
uration of "the 11 most common complaints noted in the 
climacteric patient" (Delaplaine et al., 1952, p. 326). 
Apparently, the authors' combined clinical experience 
provided the baseline from which the 11 complaints of this 
index were chosen. It was reported that 
... the menopausal index, while it is an arbi-
trary method of determining the severity of the 
patient's symptom complex, permits a statistical 
classification of the patient (Delaplaine et 
al., 1952, p. 326). 
The population of the 1952 study consisted of women 
ages 26 to 51+, who were undergoing complete hysterec-
tomies, including the removal of both ovaries. One group, 
used as controls, received routine care while the experi-
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mental group received estradiol pellet implantation at the 
time of the surgery_ Each group was evaluated by two 
means: vaginal smears for estrogenic effect and measure-
ment by the "menopausal index." 
The symptoms included in the index were: vasomotor 
changes, paresthesias, insomnia, weakness or fatigue, 
palpitations, arthralgias and myalgias, headaches, and 
formication (the feeling that insects are crawling over 
the skin). Each subject was asked to rate the severity of 
each symptom from none (0) to severe (3). A sum of scores 
for all 11 symptoms was recorded and an unknown computa-
tion was done to render a score for another scale. The 
reader was left in the dark as to the mathematical 
manipulation of the data, for the authors did not explain 
the details of that computation. However, a woman with a 
total score of 0 to 5 was rated as having "none" or no 
score on the menopausal index. A total score of 5 to 10 
indicated a "mild" classification. Ten to 15 total points 
represented the "moderate" score on the index, while 15 
and above was considered a "severe" rating. 
It was concluded that the vaginal smears and the 
results of the menopausal index complemented each other 
and the index was "successfully used as a criterion of the 
severity of the menopausal syndrome" (Delaplaine et al., 
1952, p. 332). Thus, the first trial of a menopausal 
index was completed. Two major assumptions of these 
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authors were that the vaginal tissue alone reflects the 
true severity of the perimenopause upon a woman, and that 
the computations, although not elaborated upon, were 
valid. 
Again in 1952, many of the same authors (Kupperman et 
al., 1952, p. 365) reported the use of the same menopausal 
index linked with an amenorrhea index. This combination 
was used to evaluate the efficacy of hormone compounds for 
treatment of menopause. The authors noted that, 
... the amenorrhea index (A.I.) represents the 
factor obtained by multiplying the extent of 
withdrawal (bleeding noted after progesterone 
therapy) by the quotient obtained by dividng the 
duration of bleeding by the time of onset of 
bleeding after a single intramuscular injection 
of 100 mg of progesterone to a patient prev-
iously primed by 3 weeks therapy with the 
estrogen to be evaluated (Kupperman et al., 
1952, p. 365). 
The computations or "conversion factors" of the 
menopausal index were also discussed. The authors weighed 
the symptoms of vasomotor changes, paresthesias, nervous-
ness, and insomnia to give these factors major importance 
in the menopausal index. It was felt by the authors that 
the two indexes, menopausal and amenorrheal, complemented 
each other in the evaluation of the estrogenic compounds. 
The following year, the authors explained how the 
symptoms in the checklist were weighted (Blatt et al., 
1953). The severity factor reported by each woman for 
each symptom was multiplied by an arbitrary number 
assigned by the authors. In the case of the vasomotor 
symptoms, the factor was 4. Parethesias, insomnias, and 
nervousness were given a factor of 2 (multiplied by 
severity rating). The other seven symptoms all had a 
factor of 1 (Blatt et al., 1953, p. 795). 
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This study also used the menopausal index to evaluate 
the efficiency of Vitamin E in relief of menopausal 
symptoms for a group of patients in a clinical setting. 
Vitamin E was evaluated, along with ethenyl estradiol, 
estrogenic substances (equine), phenobarbital, and a 
placebo. Vitamin E at the dosage of 50-100 mg a day was 
not found to be any more effective in reducing menopausal 
symptoms than a placebo. 
Blatt et al. (1953) also commented on the validity of 
the menopausal index. They used two subjective scales to 
correlate with an objective measure, the vaginal smear. 
Because the measures gave equal results, the authors claim 
that each, including the menopausal index, are valid 
measures of a woman's experiences in the menopause. 
One also notes an increase since 1960 in the use of 
both the menopausal index and a checklist of symptoms in 
the research literature. Neugarten and Kraines (1965) 
refer to the same 11 symptoms of the menopause as cited in 
the original article. These authors refer to the "Blatt 
Menopausal Index" as the menopausal index. Women in this 
study were drawn from the general community rather than 
from a clinical setting. Mothers of high school graduates 
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in the Chicago metropolitan area were first surveyed. 
Then, the study was expanded to include women of all ages 
(13 years upward). Neugarten and Kraines (1965, p. 267) 
noted, 
Accurate information regarding the incidence of 
symptoms among menopausal women is lacking, 
since women who do not seek medical attention 
are, for the most part, not included in clinical 
studies. 
Neugarten and Kraines (1965) used a checklist of 28 
symptoms, including the 11 cited in the BMI. The check-
list was administered to the study population twice, and 
it was found that the 11 symptoms from the BMI differ-
entiated the menopausal group from all other age groups. 
The significant finding was that the BMI would differ-
entiate menopausal women from pre- or postmenopausal 
women. 
In 1969, Jaszmann, Van Lith and Zaat published a 
study which also used the BMI on a nonclinical population. 
Over 1,000 women in the study were surveyed for menopausal 
complaints. It was found that the number of complaints 
rose during the premenopausal and menopausal time periods. 
There was a peak at the beginning of the postmenopausal 
period for symptoms of perspiration, tingling sensation of 
the arms and legs, and ache in bones, joints, and muscles. 
Similarly, the EMI scores among subjects were also found 
to peak at the beginning of the postmenopausal period and 
then gradually fell away. 
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This survey by Jaszmann et al. (1969) examined a 
number of factors found to influence a woman's perception 
of the menopause. The authors began by conducting an 
exhaustive search of the research literature which 
revealed that such factors as age at menarche, number of 
pregnancies, age at final pregnancy, financial income, 
level of education, marital status, and physical type --
light, normal and heavy -- all had bearing on a woman's 
view of the menopause. Then the authors attempted to 
validate these findings with their own research. 
They (Jaszmann et al., 1969) divided their subjects 
into groups according to the phase of the menopausal 
transition they were currently experiencing. Each group 
(premenopausal, menopausal and postmenopausal) was rated 
according to the BMI. No significant differences emerged 
between women of different physical types. More meno-
pausal complaints were reported, however, among women who 
had late menarche, women who had had at least one preg-
nancy, had been pregnant for the final time at the higher 
range of ages, were from the lower income group, had only 
a primary education, or had been married. It was found 
that these factors did not interact; each factor was 
significant only by itself. These findings were opposite 
to those which had been reported by previous researchers. 
Researchers of other aspects of the menopause were 
also finding their results differed from earlier studies. 
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For example, a study of women in a clinical setting was 
conducted in Scotland (Thompson, Hart & Durno, 1973). 
Female patients of a general medical clinic were studied 
for the presence of the climacteric and hot flash. These 
symptoms included night sweats, sleeplessness, depression, 
headaches, dizzy spells, palpitations, tiredness, joint 
pains, bloatedness, backache, swollen ankles and general 
gynecological complaints -- specifically bleeding problems 
(Thompson et al., 1973). The decision to include these 
symptoms was based on a thorough review of the literature, 
combined with the author's private practice experiences. 
These authors also compared those women who enter the 
menopause by "artificial" means (those women who had had 
radium, x-ray or hysterectomies -- with or without removal 
of the ovaries) with those women who enter the menopause 
"naturally" through nonintervention methods. They found 
that the "artificial" group had longer periods of hot 
flashes and a higher number of other symptoms than the 
natural menopause group. 
Bungay, Vessey and McPherson (1980) studied a group 
of men and women to determine the incidence of menopausal 
symptoms in both groups. Care was taken that the term 
"menopausal" was not used in this nonclinical study. The 
symptom checklist included both those symptoms appearing 
in the BMI and those added by Neugarten and Kraines 
(1965). In addition, questions concerning problems with 
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sexual relations were added. Although the authors found 
clear evidence associating the hot flash with menopause, 
no other symptoms were found to be significantly asso-
ciated with the menopausal state. 
Sharma and Saxena (1981) developed a checklist, also 
based on the one compiled by Neugarten and Kraines (1965). 
Three subsets of questions dealt with hot flashes, other 
climacteric symptoms, and menopausal status. Women of 
Veranasi City, India between the ages of 40 and 55 were 
interviewed, using the checklist plus related questions. 
The authors found the perimenopausal period was more 
"distressful" for Indian women than for Western women. 
Moore (1981) examined women in an African community 
using a symptom checklist. The occurrence of symptoms in 
the African community was similar to results in Western 
societies. 
Frey (1981), in a study of women's symptoms using a 
checklist, found the most frequent symptom was feeling 
tired. In order of decreasing incidence were the symptoms 
of feeling blue or depressed, forgetfulness, headaches, 
and finally, feeling irritable and nervous. The "most 
worrisome symptoms" in descending order of importance were 
tired feelings, forgetfulness, feeling blue or depressed 
and weight gain. Frey also concluded that her 
... subjects in general did not view the meno-
pause through an illness-orientation. Thus, the 
problems occurring during the menopause could be 
interpreted as alterations in wellness, rather 
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than illness states (Frey, 1981, p. 35). 
Also significant to this study was the finding that women 
who were employed reported fewer symptoms than those who 
were not. 
In 1984, Walfisch, Antonovsky and Moaz conducted a 
study in North Africa using an interview technique in a 
clinical setting. Forty-seven women rated 15 symptoms. 
If they had experienced the symptom, they rated the 
symptoms as occurring with low, medium or high frequen-
cies. They found that 50% of the women reported occur-
rence of some symptoms with 10 to 30% having sufficiently 
severe symptoms to necessitate a visit to the doctor. 
They found no differences among the premenopausal, 
menopausal and postmenopausal groups of the study, in 
relation to the severity or numbers of symptoms. They 
also investigated the women in the sample in relation to 
visits to the doctor and a self-assessed health status 
inventory. They found no relationships between these 
factors and the menopausal phase. 
In conclusion, only three studies were taken from 
nonclinical populations. These were the Neugarten and 
Kraines study (1965), the study by Jaszmann et al. (1969) 
and the study by Bungay et al. (1980). The great majority 
of studies examined were conducted with clinical popula-
tions. 
The original index (BMI) developed by Delaplaine and 
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associates (1952) has been reused and modified as a result 
of much research on menopause. All authors have attempted 
to explain the reasons for their own additions and/or 
deletions to the BMI. Checklist studies have been 
repeatedly used and have some degree of validity and 
reliability in separating menopausal from premenopausal 
women. This differentiation is the only consistent 
finding in all the studies reviewed. 
Factors Influencing A Woman's 
Perception of Menopausal 
Symptoms 
Culture. Studies which used the symptoms checklist 
approach have also revealed other factors which influence 
a woman's perception of the perimenopausal transition. 
Culture, aging and sexism have been cited as factors that 
may modify or alter a woman's expectations and perceptions 
of the menopause. This section deals with these issues. 
Moore (1981), Sharma and Saxena (1981), Flint (1979) 
and Flint and Garcia (1979) have suggested that the 
culture a woman lives in affects her perceptions of 
menopausal symptoms. The direction of the influence is 
unclear. For example, Flint (1979) found that 483 women 
of the Rajput caste in India had fewer menopausal com-
plaints than Western women. She attributed this to the 
fact that at menopause, an Indian woman gains status by 
being allowed to leave the previously-enforced seclusion 
from men. On the other hand, Sharma and Saxena (1981) 
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also studied women in India. They reported that women had 
a more "distressful time" in the perimenopausa1 period 
than did Western women. 
Flint and Garcia (1979), studying Jewish and Cuban 
women, found very clear differences between the two 
cultures. A questionnaire was used that focused on six 
areas: (a) personal information -- self-image and 
attitudes toward the climacteric; (b) a symptom checklist 
adapted from Neugarten and Kraines (1965); (c) 5 questions 
concerned with women's visits to physicians during the 
perimenopausa1 period; (d) questions regarding sexual 
behavior before and after the climacteric; (e) questions 
about attitudes concerning sex in general, and (f) 
personal sexual feelings. Flint and Garcia (1979) claimed 
that they could correctly predict to which group a subject 
belonged if they knew the answers to these questions. 
Kay, Voda, Olivas, Rios and Im1e (1982) found that 
while both groups reported having hot flashes, Ang1o- and 
Mexican-American women differed in their perceptions of 
the hot flash. Anglo-American women had negative connota-
tions of the hot flash, while Mexican-American women did 
not. 
Davis (1982) studied women in a Newfoundland village 
whom she found had a very negative attitude toward 
menopause. She reported, however, that the same symptoms 
of menopause were present in this isolated culture as in 
Western society. Neri, Bider, Ovadia and Ovadia (1982) 
found significant differences of experiences and percep-
tions of menopause among five ethnic groups in Israel. 
Many authors report that culture is a significant 
factor in a woman's perimenopausal experience. However, 
the nature of the differences documented in differing 
cultures has not been precisely defined. 
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Aging and sexism. Van Keep and Kellerhals (1972) 
introduced a different concept of aging in women suggest-
ing that women be classified not by chronological age 
solely, but by a combination of chronological age, social 
age, and menstrual age. It was felt that all these 
factors combine to give the woman a perception of her 
aging. 
Flint (1982) called attention to the preoccupation of 
women in the 40 to 60 age group with all facets of aging. 
She stated that the climacteric is just a part of the 
general concerns women face as they age. With declining 
energy, increased financial and social problems, and 
difficulty entering the work force at this age, the 
symptoms woman may experience are perhaps magnified more 
than they would be without these complicating factors. 
She cited the new value of independence for women in the 
United States as a possible contributor to the uncertainty 
women of this age often encounter. In this country, many 
of the now perimenopausal women have exclusively tended 
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hearth, home, and children for the majority of their adult 
lives (Flint, 1982, p. 179). Becoming independent is not 
easily accomplished by all women in this group. 
Alington-Mackinnon and Troll (1981) note, 
One assumption generally characteristic of 
attitudes toward aging is that all age-related 
changes are, by definition, degenerative. That 
is, regardless of their possible value in terms 
of species survival, they are maladaptive in 
terms of the individual. Like other age-
dependent changes in adulthood, the menopause is 
perceived as a symptom of bodily decline, it is 
abhorred for that which it symbolizes as much as 
for it's own sake ... Rather, the menopause is 
widely perceived as the beginning of the end (p. 
349). 
Thus, one's perception of the menopause may be greatly 
influenced by the woman's feelings about aging, in 
general. 
Feminist writer Rosetta Reitz states that the 
climacteric for her had more to do with her financial 
concerns and her resolve to be more independent than with 
her ovaries. Much of the same information is mirrored in 
Our Bodies, Ourselves (Boston Women's Health Book Collec-
tive, 1976). Moss (1970) asserts that aging and sexism in 
America combine against the maturing women to make her 
useless in society. The climacteric, she stated, is only 
a small piece of this. 
One of the most thought-provoking views was provided 
by Posner (1979). The author traces the history of the 
medical model of the menopause and compares it with the 
feminist model of menopause. Posner states that the 
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medical model conceptualizes the menopause as a deficiency 
disease complicated by "psychological factors." Stated 
differently, some symptoms may be completely psychological 
in nature, with some authors arguing that those women who 
were and are more "stable" (i.e., well-adjusted, married, 
without evidence of mental illness, etc.) will have fewer 
symptoms (Dewhurst, 1976, p. 542). 
The feminist model asserts that much of the exper-
ience of menopause may be attributed to what a woman 
believes, rather than to physiological events in her body. 
Hence, both the medical and the feminist groups reach 
their conclusions via different routes. Specifically, 
both conclude that nonbiological events exert much control 
over a woman's experience in menopause. It remains to be 
seen what future investigators will conclude because the 
present models reflect personal views rather than research 
efforts to distinguish between feminist models and other 
perceptions. 
Factors that Relieve, Postpone 
or Mask Menopausal Changes 
Estrogen replacement theory. Both the feminist and 
medical communities have written extensively on the 
advisability of estrogen replacement to relieve discom-
forts and prevent tissue changes that take place during 
the climacteric. There are many protocols and arguments 
for and against the use of estrogens, alone or in combina-
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tion with other hormones. Those arguments do not directly 
apply to this study; therefore, a detailed account of them 
will not be given. It must be noted, however, that it is 
widely agreed that the use of compounds containing 
estrogen, progesterone, other steroid hormones, and 
vasoactive drugs do mask, alleviate, or postpone symptoms 
of the menopause (American Council on Science and Health, 
1983; Barr, 1975; Callantine, Martin, Bolding, Warner & 
Greaney, 1975; Dewhurst, 1976; Lightman & Jacobs, 1979; 
Coope, Williams & Patterson, 1978; Tulandi, Kinch, Guyda, 
Mazella & Lal, 1984). When women in the menopause are 
included in research studies, it is necessary to determine 
their hormonal status whether they are taking these 
chemicals or hormones or not. Failure to do so could 
distort the results of any project. 
Lifestyle traits. In her milestone book published in 
1977, Reitz listed many lifestyle changes that have been 
reported to relieve various symptoms of menopause. These 
are also mentioned in works by other authors (Getchell, 
1979; Greenwood, 1984; Porcino, 1983; Voda, 1984). 
Exercise, reaching orgasm regularly, good nutrition and 
careful selection of health care provider are the major 
suggested modalities. These suggestions are the result of 
the authors' personal and clinical experiences, rather 
than the result of research studies. 
Exercise. Exercise, Reitz states, is necessary for 
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life and should be done daily at this period of a woman's 
life. She recommends walking (Reitz, 1977). Porcino 
(1983) states that "vigorous exercise -- daily or several 
times a week -- is essential to growing old gracefully and 
zestfully" (Porcino, 1983, p. 199). Voda (1984) also 
notes exercise to be of benefit to this population, 
particularly to help maintain healthy bones. 
Other benefits of exercise include decreased risk of 
cardiovascular disease, less insomnia and a decrease in 
the occurrence of depression and anxiety (Porcino, 1983). 
Greenwood (1984) reiterates these points and also notes 
regular exercise will improve one's appearance. 
A recommended exercise program for the older adult is 
30 minutes of exercise four times per week as a minimum. 
A heart rate of 130 to 140 beats per minute should be 
sustained over the 3D-minute time period provided the 
woman is medically healthy (after consultation with and 
approval of a health care provider) (Getchell, 1979). 
Sexuality. Disturbances in sexuality of the woman in 
the menopausal transition have been cited by many authors 
(Coope, 1984; Jones & Jones, 1981; Moaz & Durst, 1980; 
Porcino, 1983; Reitz, 1977; Semmens & Semmens, 1984; utian 
& Serr, 1976; Voda, 1984). Most report that atrophic 
vaginitis often occurs during this period due to decreased 
amounts of circulating estrogens and is a major cause of 
these disturbances. Less estrogenic influence on the 
vagina may leave the vaginal tissues thinner and more 
friable -- more easily damaged -- during intercourse. 
This, in turn, leads to painful intercourse. It is of 
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interest that this does not occur in all menopausal women 
(Jones & Jones, 1981). 
Semmens and Semmens (1984) discussed their study in 
which decreased vaginal secretions were studied in 
relationship to circulating estrogen and supplemental 
estrogen. These authors felt that as secretions were 
decreased, the negative effects these women experienced in 
relation to their sexuality were increased. Their study 
provides new information on the use of estrogen in the 
climacteric years. 
Researchers have addressed ways in which these 
negative effects have been, or can be, modified. Some 
believe that if a woman reaches orgasm regularly, by 
whatever means, atrophic vaginitis or painful vagina may 
be postponed (Porcino, 1983; Reitz, 1977). Mastroianni 
(1985) reports that women who are sexually active are 10 
kilograms heavier than those who are not. He maintains 
that the extra adipose tissue is involved in estrogen 
storage and may assist in making the climacteric transi-
tion less stressful. 
Reitz (1977), Voda (1984), and Coope (1984) have 
described some physiological changes that occur in both 
men and women at this time that may account for changes in 
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sexuality. They cite age-related changes in lifestyle, as 
well as those changes peculiar to women (i.e., hormone 
changes). All three suggest practical strategies for 
modifying these changes that range from exercise to using 
a lubricant, to the use of supplemental hormones. These 
authors suggest that the field of sexuality in the 
menopausal woman will be an important avenue of future 
research. 
Lastly, Coope (1984) details many problems encoun-
tered in the later years that have an impact on sexuality. 
She discusses many different means of modifying problem 
areas, but cites no research findings to substantiate her 
claims. 
Nutrition. Proper nutrition, or lack of it, affects 
everyone's lives. Women in the perimenopausal transition 
are no exception. For example, because of decreased 
amounts of circulating estrogens, it becomes imperative 
that women in the perimenopausal transition take special 
care to include sufficient calcium in their diets. Women 
at this time become more prone to osteoporosis, especially 
if sufficient amounts of calcium are not present in their 
diets. It is recommended that women include at least 800 
to 1500 milligrams of calcium in their diets daily. This, 
combined with regular weight bearing exercise, is thought 
to decrease a woman's chance of developing osteoporosis 
(Eagles & Randall, 1980; Greenwood, 1984; Voda, 1984). 
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other nutritional needs do not differ from those of 
most women after the growth spurt of adolescence. Women 
aged 23 to 75 need about 44 g of protein each day (Eagles 
& Randall, 1980). There are no RDA requirements for fat 
or protein. It has been reported that 45 to 50% of the 
American diet is composed of carbohydrates, both complex 
and simple (Mitchell, Rynbergen, Anderson, & Dibble, 
1968). The American Heart Association recommends that the 
combined content of unsaturated and saturated fatty acids 
in the diet should not exceed 35% of the entire caloric 
intake. There have been no reported differences in this 
age group of women for other vitamins, minerals or trace 
elements. 
Reitz (1977) argues that a woman who maintains a 
healthy diet will have fewer problems during menopause 
than one who neglects her nutritional needs. This 
argument is not based on scientific research findings. 
Mastroianni (1985) stated that nutrition and age-related 
changes are very important in relation to the climacteric 
but need further research. 
Health care provider. Porcino (1983), Reitz (1977) 
and Voda (1984) recommend that a woman passing through the 
perimenopausal transition should consult with a health 
care provider and cite the importance of using care in 
choosing a provider. Specifically, Voda (1984) suggests a 
nurse practitioner or physician who is knowledgeable in 
the field and will take the time to listen to each woman 
before recommending treatment. 
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An interesting study by Holzman, Ravitch, Metheny, 
Rothert, Holmes and Hoppe (1984) found disparity between 
what a physician's stated beliefs about estrogen were, and 
their likelihood to prescribe estrogen after reading case 
histories. Their stated beliefs did not correlate with 
their hypothetical answers to case presentations. In view 
of these findings, women in this period should give 
careful consideration to selection of their health care 
providers. 
In summary, there are factors other than physio-
logical change that may influence a woman's experiences 
with menopause. Research in the area of modifying factors 
is limited. It is necessary to account for these poten-
tial contributing factors, however, when studying the 
menopausal experience in order to understand why similari-
ties and differences between women occur. 
Summary 
Many studies of menopause have been conducted using a 
symptom checklist based on the the BMI. Some researchers 
combine an index developed by Neugarten and Kraines (1965) 
from the BMI with a checklist of symptoms observed in 
clinical practice. The majority of studies used the 
symptoms included in the BMI. The BMI, by the original 
authors' admission, was an arbitrary list of symptoms. 
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This investigator questions whether the 11 symptoms of the 
BMI do, in fact, represent women's experiences. 
Many of the studies are incomplete for several 
reasons. In some studies, the populations were women who 
presented to clinicians complaining of menopausal symp-
toms. Women who had no complaints, or those who did not 
seek medical care for menopausal complaints were not 
included in all studies. Further, there is much contro-
versy over the cultural biases of some studies. Actual 
populations of the studies have been criticized for these 
reasons. 
An important criticism is the utilization of check-
lists at all. Donovan and Rochester (1951) seriously 
questioned the use of checklists because they felt the 
lists suggested symptoms to women that they might not have 
complained of if unprompted. They felt that subjects may 
have agreed they had such symptoms in order to receive 
care and attention. When they interviewed women repeated-
ly, they found the symptoms changed from week to week. 
When they gave the women no reinforcement for their 
symptoms (by not giving attention to them), the women 
returned the next week with differing symptoms. This 
occurred even while carefully maintaining a caring and 
sympathetic attitude toward the women. Donovan and 
Rochester suggested a complex interaction existed between 
health care provider and patient. 
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These problems led this author to develop a descrip-
tive study in an effort to avoid many of these drawbacks. 
Although a checklist was used, Donovan and Rochester's 
(1951) criticism may be applicable to this study also. 
However, most of the other factors they criticized were 
avoided. The primary purpose of the study was to deter-
mine what symptoms of the menopause women in a nonclinical 
setting were experiencing. A second component of the 
study was a determination of those factors which relieve 
or moderate menopausal symptoms. 
conceptual Framework 
Menopause, or more specifically, the perimenopausal 
transition, is a complex process involving psychological, 
physiological, developmental and cultural issues. 
Researchers have traditionally used models, frameworks or 
theories to organize such complex issues in order to 
understand the relationships among the many variables. 
During the review of literature, no specific theory or 
model explaining the phenomena was universally proposed. 
Rather, the literature suggests many theories to account 
for various aspects of women's experiences in the meno-
pause. 
The most comprehensive approach was presented by two 
registered nurses, Millette and Hawkins (1983). They 
propose that many factors influence a woman's experience 
in the menopause. These can best be understood by 
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reviewing the model presented in Figure 1. 
Millette and Hawkins (1983) discussed the physio-
logical events of menopause, such as the decline in 
circulating estrogen, the involution of the ovaries, and 
the differences experienced between surgical menopause and 
gradual menopause and emphasized the very individual 
experiences women have during this period. These events 
are compared with the changes that women experience in and 
around menarche, and the authors stated that the two 
events, menarche and menopause, were but milestones in 
women's lives. 
Millette and Hawkins (1983) also discussed the 
confusion that exists between symptoms of aging exper-
ienced by both men and women and symptoms of physiological 
events of menopause. They assert that there is some 
confusion among both men and women into which category 
(aging versus menopause) the various symptoms belong. 
Many psychologists, Duvall (1971), Erikson (1963), 
Havighurst (1972), and Peck (1968) have discussed the 
developmental tasks attributed to the middle years. 
Millette and Hawkins (1983) state that many of the 
developmental theories are based on the male model, and 
may not be applicable to women. Further, they agree that 
such models need modification to account for women's 






















Figure 1. Factors influencing a woman's experience 
in the menopause (Adapted from Millette 
& Hawkins, 1983). 
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agree that the middle years are years of great change and 
each theorist specifies developmental tasks for women of 
this age. Whether a woman completes these specified tasks 
or not supposedly has a marked impact on her life. 
The psychosocial issues that Millette and Hawkins 
(1983) refer to are those that the American culture 
imposes on its aging women. The emphasis on youth, the 
high value of a woman's reproductive ability, society's 
tendency to judge a man by his financial success and a 
woman on her looks, as well as a cultural heritage that 
depicts the menopausal woman as barren and empty, are all 
factors which combine to cause American women to view 
menopause in a negative way. The women's movement has had 
some positive impact on this negative outlook, but it is 
felt that these issues are still valid today. 
Self-care habits also affect the perimenopausal 
transition, as does the health care provider one chooses 
to consult. These two factors influence each other, as 
well as all other factors in the model. The symptoms may 
be tolerated well in a healthy, robust woman, but may be 
very debilitating in a woman with failing health. 
Emphasis of a health care provider on positive health 
habits versus indiscriminate use of hormones could 
probably also have an impact on a woman's experiences. 
All of these factors influence each other indi-
vidually and collectively, with still unknown or undis-
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covered factors yet to be added. This is shown in the 
model by the arrows which point from each factor to the 
others. The perimenopausal transition is the result of 
many factors combined. With this model as a framework, a 
questionnaire was compiled to investigate women's exper-
ience in the menopausal transition (Appendix B). 
Problem statement 
This study was formulated to address the situation of 
women who were experiencing the perimenopausal transition. 
The major goal was to allow women in a nonclinical setting 
to describe their experiences of this transition. 
Research Questions 
Ten research questions were developed to further 
define the parameters of this phenomenon. These were: 
1. What symptoms of the menopause will women in 
a nonclinical population report most often? Will 
those women report the same number and kind of 
symptoms of the menopause in answer to an open ended 
versus a checklist questionnaire? 
2. Will women who take hormones or vasoactive 
drugs and those who do not report the same number and 
kind of menopausal symptoms. 
3. Will women who are premenopausal, menopaus-
al, and postmenopausal, report the same number and 
kind of menopausal symptoms? 
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4. Will women who list the same symptoms(s) in 
the open-ended questionnaire and the checklist 
questionnaire rate the severity of the symptom(s) 
equally? 
5. How many women have talked with their health 
care provider about menopause? 
6. What percentage of women who consider 
themselves in the periperimenopausal transition are 
taking hormone preparations or vasoactive drugs? 
7. What percentage of symptoms reported on the 
questionnaire will women report were also experienced 
before the perimenopausal transition? 
8. How much will women state the perimenopausal 
transition has affected their daily lives? 
9. Will women who have certain demographic or 
lifestyle traits have less severe symptoms than women 
without those traits? 
10. What will be the reason(s) given by women 
that tell them they are in the perimenopausal 
transition? 
Assumptions and Limitations 
Assumptions 
Certain assumptions and limitations are specific to 
the type of design used in this study. Five assumptions 
are applicable to this research. 
1. Menopause is limited by definition to women. 
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2. All women (with few exceptions) menstruate, 
and pass through a menstrual transition, reproductive 
period, perimenopausal transition, and menopause. 
3. More information from women experiencing the 
perimenopausal transition is needed by health practi-
tioners in order to provide better care. 
4. Women experiencing the perimenopausal 
transition are the best source of information about 
this life period. 
5. Women will volunteer to participate in a 
study to further knowledge of perimenopausal transi-
tion and will be able to factually report the 
symptoms they experience. 
Limitations 
The limitations of the study are based primarily on 
the type of research design used. These areas are 
especially critical for interpetation of the data. First, 
because the questions in the study required recall of 
information, the study was likely to evidence some errors 
resulting from the inability of the subjects to accurately 
relate past information. 
Second, the results are not generalizable to the 
entire population of women in the perimenopausal transi-
tion because of nonrandomization and use of a small 
convenience sample. Finally, some error of reporting may 
result because of misrepresentation of subjective data 
contributed by each respondent. In addition, the fact 
that each woman was free to interpret questions may have 
led to misunderstandings of the questions. 
Rationale and Significance 
of the Study 
Nurse clinicians, like their medical counterparts, 
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are concerned with the detection, diagnosis, and curative 
aspects of treating pathological states in their clients. 
Nursing theory and education also highlight the psychoso-
cial aspects of patient care management. Preventive 
health measures, health education, and anticipatory 
guidance have long been considered essential to the 
practice of nursing. The nurse clinician must tailor 
interventions to the individual, focusing on health 
promotion as well as control of symptoms. 
The situation in which a woman entering the peri-
menopausal transition finds herself may not fit exactly 
with any particular theory or intervention. The nurse 
clinician, after careful review of the literature of the 
perimenopausal transition and the unique situations in 
this period of the client's life, must base the management 
plan on some theoretical belief about menopause. This 
theory needs to reflect the complexity of changes that are 
taking place during this time. 
The review of literature and conceptual framework 
have highlighted current thought on the complexity of the 
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perimenopausal period. Even primary definitions of the 
terms currently used to describe the perimenopausal period 
are often confusing and contradictory. Studies have often 
been based on small clinical populations of various 
cultural groups. The need for studies of varied groups, 
nonclinical populations, and various cultures has been 
documented. 
In order for nurses to assist perimenopausal women, 
the nurse clinician's plan must be based in solid theory 
that incorporates all the factors involved in the process. 
A need for more knowledge of all women, with and without 
perimenopausal symptoms, is needed in order to establish 
the first level of theory (i.e., to describe the phenome-
na). This study will add to the body of knowledge 
concerning menopause, and together with other projects, 
assist in developing a clearer description of the woman in 
the perimenopausal transition. A logical and concise 
description of these phenomena will have a positive 
influence on women's health care. 
CHAPTER II 
DESIGN OF THE STUDY 
Design 
This was a descriptive study utilizing a survey of 
women volunteers. Women were recruited to answer a 
questionnaire dealing with their experiences during the 
menopause (Appendix B). A convenience sample consisted of 
volunteers aged 37 to 72, who answered the newspaper 
and/or other media advertisements, or were contacted 
through their women's club or group_ 
Setting 
A letter describing the study was sent to all women's 
clubs meeting in the target area who were listed on the 
"Idaho Women's Groups Information and Referral List 
9/1982." A meeting with the women's group was scheduled 
via follow-up phone calls 1 week after the letter was 
sent. Church, school, and community groups were also 
contacted by phone to determine: (a) potential interest 
in this study, and (b) that a signficiant number of the 
members were in the target age group of 40 to 55 inclu-
sively. The same letter describing the study sent to the 
women's clubs was also sent as a follow-up to those 
church, school, and community groups from whom positive 
phone responses were obtained. 
Population 
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The target pouplation for this study was all women 
between the ages of 40 and 55 inclusive who resided in the 
greater metropolitan area of Boise, Idaho (located in Ada 
County, Idaho). After data collection, the age range was 
expanded, due to too few respondents who fit the 40 to 55 
age group. The new age range included all women who 
stated they were in the menopause and ranged from 37 to 72 
years of age. 
It was determined by the 1980 United states Census 
Report that in this area, women between the ages of 36 and 
74 (inclusive) numbered 23,466 (Bureau of the Census, 
1980). Less than 0.3% of this female pouplation is black 
and less than 2% claim Spanish origin. No other signifi-
cant racial, ethnic, or cultural groups were listed. 
Sample 
Volunteers were obtained across a wide range of 
women's clubs and community, school, and church groups in 
the target area. Groups who stated they had a significant 
number of members whose ages fell between 40 and 55 
inclusive and who wished to participate in the project 
during the data collection period were included in the 
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study. Women who contacted the investigator individually 
were invited to a group meeting. For the purposes of this 
project, all women present during each meeting filled out 
a questionnaire regardless of age. Only those women who 
stated they were in the menopause or "change of life," 
were included in the study. Data from questionnaires of 
women not meeting the above criteria were not used in this 
study. It was the opinion of the investigator that 
screening the group prior to administration of the tool 
would have been unwise for at least two reasons: 
1. Isolating the age groups would have been diffi-
cult due to the variety of settings; 
2. Women who did not meet the criteria but showed 
interest in the project may have benefitted from filling 
out the questionnaire. 
Data were collected from 205 women over a period of 3 
1/2 months. After this time period, the data collection 
was discontinued. The final sample for data analysis 
consisted of 78 women who stated they were in the meno-
pause and completed the questionnaire. 
Operational Definitions 
The following operational definitions were used to 
clarify the research questions. 
Menopause 
Menopause is that point in time when a woman no 
longer has menstruation; it is, in fact, the last men-




The term, perimenopausal transition, is used to 
include a period of time prior to the menopause (from 
months to years) when a woman begins to have changes in 
her menses (or other events that can be directly related 
to ovarian failure) and at least the first year after the 
menopause. 
Premenopause 
Premenopause is defined as the period in a woman's 
life from menarche to menopause. 
Postmenopause 
Postmenopause is the period of time in a woman's life 
from menopause to death. 
Symptom 
A sign, indication or feeling of change that is 
observed by a person, especially if it indicates disease 
or altered health is considered a symptom. 
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Hormone 
A sex hormone is any substance (natural or synthetic) 
that is carried by the bloodstream and has a physiological 
effect on any of the reproductive organs of the body. 
vasoactive Preparations 
Vasoactive preparations are drugs that affect the 
vasculature of the body causing dilation or constriction 
of the blood vessels either as a direct/desired effect or 
a side effect. These drugs include: all hormone prepara-
tions, cafergot, tenormin, wigraine, propanolol and 
lopressor. 
Lifestyle Trait 
A characteristic or habit that one may choose is 
considered a lifestyle trait. For this study, these 
include exercise, amount of calcium, protein and fat in 
the diet, calorie intake, seeing a health care provider 
and talking with someone about menopause, being sexually 
active and using hormones or vasoactive drugs. 
Health Care Provider 
The term health care provider is defined as any 
person from whom advice may be obtained on a formal basis 
concerning one's physical or mental well-being. 
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Perimenopausal Group 
In this investigation, the perimenopausal group was 
comprised of all women who stated they were in the 
menopause. These included members of the following 
groups: premenopausal, menopausal, postmenopausal, users 
of hormone preparations or vasoactive drugs and those who 
did not take hormones or vasoactive drugs. 
Hormone/Vasoactive Drug 
Users (Group HI) 
All women (premenopausal, menopausal or postmeno-
pausal) who claimed to be menopausal and stated they had 
used an estrogen, progesterone, or other vasoactive 
hormone drug(s) within the past 5 years were considered 
members of the hormone/vasoactive drug users group. 
Nonhormone/Vasoactive Drug 
Users (Group H2) 
All women who stated that they had used no hormones 
or vasoactive drug(s) within the past 5 years were 
included in the nonhormone/vasoactive drug users group. 
PremeJ:"l.0pausal Group 
(Group MI) 
All women who had a menstrual period within I year of 




Women whose last period was at least 1 year previous, 
but not more than 2 years prior to answering the ques-
tionnaire were defined as menopausal. 
Postmenopausal Group 
(Group M3) 
Women who reported that their last menstrual period 
was over 2 years previous and stated they were still in 
the perimenopausal transition were included in the 
postmenopausal group. 
Nonclinical Population 
Any group of participants that are not taken from a 
listing of patients in an institution or medical practice 
were considered nonclinical. 
Data ColI 
Data were collected in the Boise, Idaho area. Sample 
groups were obtained as described in a previous section. 
Group members and other individuals who asked to partici-
pate in the study were invited to call or write such 
response to the investigator. A meeting time and place 
were arranged that was acceptable to both investigator and 
host group. 
At these meetings, a short explanation of the project 
was given which included the following: 
1. Introducton of investigator; 
2. Explanation of investigator's interest in 
menopause; 
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3. Use of data to be collected to explain the body 
of knowledge of menopause; 
4. Confidentiality of the data; 
5. Subject consent forms -- explained, signed, and 
collected; 
6. Proposed order of events: 
6.1 Part I distributed and answered indi-
vidually by the women, then collected; 
6.2 Part II distributed and answered indi-
vidually by the women, then collected; 
6.3 Questions from the group; 
6.4 Presentation if applicable; 
7. Presentation included: 
7.1 Review of literature regarding menopause; 
7.2 Definition of terms (premenopausal; 
menopausal; last menstrual period [LMP]; postmeno-
pausal); 
7.3 Current therapies (particular attention was 
given to the presentation of these therapies to 
insure that they were presented in a nonjudgmental 
way) : 
7.3.1 estrogen, 
7.3.2 estrogen and progesterone combina-
tions, 
7.3.3 others, 
7.3.4 need for individual consultation 
with health care provider; 
8. Thanked club and subjects and departed. 
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A major data collection error was discovered during 
the fifth week of data collection after approximately 75% 
of the subjects had answered the questionnaires. As the 
investigator was beginning preliminary coding, it was 
found that the last page of the questionnaire was missing. 
This was traced to the investigator who, when printing out 
the questionnaire from computer files, chose an earlier 
version of the file in error. 
After consultation with the supervisory committee, 
the investigator elected to contact each study participant 
who met the criteria for inclusion in the study. The 
participants were then asked to answer the missing ques-
tions during a follow-up telephone interview. This was a 
time-consuming option as telephone numbers had not been 
included in the questionnaire. Illegible writing and 
telephone numbers listed under a spouse's name compounded 
the problem. This follow-up expanded the data collection 
period from 6 to 14 weeks. However, 76.9% of the missed 
sample population was eventually reached. 
In conclusion, data collection was delayed and the 
design of the study modified because of a data collection 
error. Data collection consisted of administering a 2-
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part questionnaire with a follow-up phone interview 7 to 
28 days later. The nutritional data were not obtained for 
the entire group; 23.1% of the sample were not contacted. 
With this exception, the study was conducted as planned. 
CHAPTER III 
DATA ANALYSIS 
This study was descriptive in nature with a limited 
volunteer sample group. The data obtained were nominal 
and ordinal in nature. Descriptive statistics were used 
to analyze the data. Nonparametric statistics were 
appropriate to the study and were, therefore, utilized. 
The data analysis is divided into two sections: (a) 
demographics, and (b) research questions. 
Demographics 
The demographic data collected in this investigation 
were age, race, education and family income levels (Table 
1). Comparative statistics (Bureau of the Census, 1980) 
for the Boise Greater Metropolitan Area (BGMA) were 
available for age, race, and educational levels. Only an 
average income of $19,604 for this age group was available 
from census records while more detailed information was 
obtained in this study. Each parameter is discussed 
separately. 
Table 1 
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Note. aBureau of the Census, 1980; bHigh school graduates 
above. 
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Women in the study group ranged from 37 to 72 years 
of age. The mean age was 51, the median 50, and the mode 
48, with a standard deviation of 7.147. The age range 
roughly compared to the 35 to 74 year age group from the 
census data (Table 1). This group of women span an age 
range of 39 years. Figure 2 presents a graphic repre-
sentation of the age distribution of the study partici-
pants. 
Race 
There was greater representation of the "other than 
white" groups in the sample than found in the general 
population. Census records (Bureau of the Census, 1980) 
indicated a 3.0% "other than white" group in the general 
population. The sample group had a 9.0% "other than 
white" membership. The high percentage of 5.1% Native 
American representation is the most notable in the study 
group. Secondly, the lower percentage of Spanish American 
representation in the sample than in the census data was 
apparent. 
Education 
The sample population had a higher educational level 
than the general population as represented in Figure 3. 
Only 2.6% of the sample had less than a high school 
education, while 35.7% was reported in the census data 
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Figure 2. Age distribution of study group. 
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Figure 3. Educational level of study group. 
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(Bureau of the Census, 1980). It is difficult to compare 
the sample and the general population for those women who 
were high school graduates or above because the census 
data groups all high school graduates and college groups 
together, while this study provided more detailed cate-
gories. The tendency for the study group to have 
significantly higher education was, nevertheless, appar-
ent. The mean, median and mode of the study group all 
fell within the 1 year of college category. 
Income 
The average family income level for the sample group 
fell within the $30,000 to $39,999 range as presented in 
Table 1. The mean, median and mode fell within this 
range, as well. This is considerably higher than the 
$19,606 average family income of the general population as 
reported by the u.s. Bureau of the Census (1980). Table 1 
clearly indicates a difference between the sample popula-
tion and the general population. 
In conclusion, other than the similar age character-
istics, the study population was different than the 
general population of the Boise Greater Metropolitan Area. 
Race, educational levels and income all differed markedly 
from the average presented in the census data (Bureau of 
the Census, 1980). 
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Research Questions 
This section of the data analysis will consider each 
research question individually. It should be noted that 
where appropriate, the sample has been divided into 
various subgroups according to the research questions. 
Those who used hormones and those who did not use hormone 
preparations are referred to as Groups HI and H2, respec-
tively. Those women who were premenopausal, menopausal 
and postmenopausal are referred to as Ml, M2, and M3, 
respectively. 
Research Question One 
Research question one stated: 
What symptoms of the menopause will women in a 
nonclinical population report most often? Will 
those women report the same number and kind of 
symptoms of menopause in answer to an open-ended 
versus a checklist questionnaire? 
Table 2 presents an exhaustive list of all symptoms 
reported by women in this study. The list is not ranked, 
but contains all 45 symptoms reported in both the open-
ended and checklist questionnaires. The 11 symptoms of 
the Blatt Menopausal Index (BMI) are noted with an 
asterisk in the table. These symptoms were reported in 
the open-ended portion of the questionnaire without 
prompting from the investigator. 
As can be seen in Table 3, the hot flash was the most 
frequently reported symptom for both the open-ended 
section (53.8%, n = 42) and for the checklist (87.2%, n 
Table 2 
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Most Frequently Reported Symptoms 
(n = 78) 
Symptom Open-Ended Checklist Combined 
Total % Total % Total %a 
Hot Flash 42 53.8 68 87.2 68 87.2 
Changes in 
Mensesb 34 43.6 34 43.6 
Melancholia, 
Depression 22 28.2 64 82.0 64 82.0 
Weakness, 
Fatigue 15 19.2 60 76.9 60 76.9 
Nervousness 14 17.9 60 76.9 62 79.5 
Skin Changes 13 16.7 58 74.4 59 75.6 
Insomnia 9 11.5 64 82.0 64 82.0 
Muscle, Joint 
Pain 9 11.5 62 79.5 64 82.0 
Headaches 9 11.5 62 79.5 62 79.5 
Weight Changeb 9 11.5 9 11.5 
Heart Palpitations 7 9.0 57 73.1 57 73.1 
Tingling 4 5.0 53 67.9 53 67.9 
Vertigo 1 1.3 51 65.4 51 65.4 
Note. aDuplications in open-ended questions and checklist 
have been removed; b These symptoms are not included in the 
BMI. 
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64). Overall, 87.2% of the women reported the hot flash 
in at least one of the sections. Melancholia and depres-
sion, insomnia, and muscle and joint pain were equally 
reported by the sample (82.0%, n =64). Nervousness and 
headaches were the third most frequent, with 79.5% (~ 
62) of the respondents reporting their presence. Two 
symptoms, changes in menses and weight change which were 
not included in the checklist, were included in the table 
because their incidence compared with other symptoms 
listed in the open-ended cases. 
The answers received in the open-ended portion of the 
questionnaire differed from the checklist responses. In 
the open-ended section, hot flashes were the most fre-
quently reported symptom with 53.8% (~ = 42) of the women 
reporting them. Changes in menses was the second, 
reported by 43.6% (~ = 34) of the women. A majority of 
the respondents described melancholia and depression, 
weakness and fatigue, nervousness, and skin changes. The 
other symptoms included in Table 3 under open-ended cases 
were included solely for purposes of comparison with the 
checklist symptoms as their frequencies were less than 
15%. 
Although hot flashes were the most frequently 
reported symptoms on the checklist (n = 68, 87.2%), 
insomnia and melancholia and depression were also fre-
quently noted (~ 64, 82%). It is noteworthy that all 
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symptoms in the checklist had at least 65.4% (n = 51) of 
the sample answering positively. On the other hand, the 
hot flash, the most frequent symptom listed in the open-
ended section was reported by only 53.8% (n = 42) of the 
respondents. It is of interest that in responding to the 
open-ended questionnaire, women listed the first 6 
symptoms of the checklist most frequently without coaching 
from the investigator. Only one of these symptoms, 
changes in menses, was not included in the checklist. 
Research Question Two 
Research question two stated: 
Will women who take hormones or vasoactive drugs 
and those who do not report the same number and 
kind of menopausal symptoms? 
These data were divided into women who used hormones or 
vasoactive drugs (HI) and those who did not (H2). 
According to the review of literature, the use of hormones 
and vasoactive drugs relieves or modifies the symptoms of 
the perimenopausal transition. Table 4 presents the 
symptom responses of both groups. It should be noted that 
the study population was divided exactly in half by this 
criterion. Fifty percent of the sample used hormone 
preparations and vasoactive drugs and 50% did not. The 
trend for higher frequency of symptoms noted by checklist, 
as compared to the open-ended questionnaire holds true for 
both HI and H2 groups. The further difference between the 
frequency of the two groups is best illustrated in Figure 
Table 4 
























in Hormone Group (n = 78) 
Checklist O-E Checklist 
n %d 
24 61.5 35 89.7 19 48.7 33 84.6 
11 28.2 23 59.0 
12 30.8 33 84.6 10 25.6 31 79.5 
12 30.8 32 82.0 3 7.7 28 71.8 
8 20.5 32 82.0 6 15.4 28 71.8 
9 23.1 33 84.6 4 10.3 25 64.1 
7 17.9 33 84.6 2 5.1 31 79.5 
7 17.9 34 87.2 2 5.1 28 71.8 
5 12.8 34 87.2 4 10.3 28 71.8 
9 23.1 
6 15.4 31 79.5 1 2.6 26 66.7 
3 7.7 29 74.4 1 2.6 24 61.5 
1 2.6 30 76.9 21 53.8 
6 15.4 1 2.6 
6 17.9 1 2.6 
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Note. aH1=Women who used hormone or vasoactive prepara-
tion; bH2=Women who used no hormone or vasoactive prepara-
tion; cOpen-Ended; dpercentages are based on the n of the 
group; eIndicates symptoms not on checklist questIonnaire. 
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4. 
The frequencies across all symptoms, except changes 
in menses, is less in Group H2 than in Group HI. Check-
list symptoms for both groups had higher frequencies than 
their corresponding open-ended frequencies. This is 
easily visualized in Figure 4. If the null hypothesis is 
accepted that there would be no significant difference in 
the way HI and H2 groups answered these questions, the 
probability of 14 out of 15 symptoms falling as they do in 
the open-ended questions is equal to .0005. If one 
accepts the null hypothesis for the checklist, the 
probability of 11 out of 11 symptoms falling as they do 
above is also .0005. These probabilities were taken from 
a binomial table (Yamane, 1964). 
Research Question Three 
The third research question stated: 
Will women who are premenopausal, menopausal, 
and postmenopausal report the name number and 
kind of menopausal symptoms? 
Table 5 reports the sample population in different groups. 
It should be noted that the entire population of this 
study is not included in these groups. Some question-
naires did not include the information necessary (speci-
fically the date of the last menstrual period) to deter-
mine which menopausal group the women belonged to. 
Therefore, 66 women were divided into these groups based 
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~--II H1 (Using hormones 
open-ended) 
x----x H2 (Not using 
hormones open-
ended) 
+----+ HI (Using hormones 
checklist) 
0----0 H2 (Not using 
hormones 
checklist) 




Most Frequently Reported Symptoms in Menopause 
Groups (!! = 66) 
Ml (Premenopause) M2 Menopause M3 Postmenopause 
(n=18) (n=9) (n=39) 
Open-Ended Checklist Open-Ended Checklist Open-Ended Checklist 
Symptom !! %a !!. % !!. % !!. % !!. % !!. % 
Hot Flash 8 44.4 16 88.9 5 55.5 9 100.0 29 74.4 41 100.0 
Changes in 
Mensesb 15 83.3 6 66.7 10 25.6 
Melancholia, 
Depression 9 50.0 17 94.4 2 22.2 9 100.0 10 25.6 36 92.3 
Weakness, 
Fatigue 3 16.7 14 77.8 4 44.4 9 100.0 8 20.5 35 89.7 
Nervousness 4 22.2 15 83.3 2 22.2 8 88.9 7 17.9 36 92.3 
Skin Changes 3 16.7 14 77.8 1 11.1 9 100.0 9 23.0 34 87.2 
Insomnia 2 11.1 15 83.3 1 11.1 10 100.0 6 15.4 37 94.9 
Muscle, Joint 
Pain 3 16.7 14 77.8 1 11.1 9 100.0 5 12.8 37 94.9 
Headaches 6 33.4 14 77.8 1 11.1 9 100.0 2 5.1 38 97.4 
Weight Changeb 3 16.7 1 11.1 4 10.3 
Heart Palpi-
tations 1 5.6 14 77 .8 2 22.2 9 100.0 4 10.3 33 84.6 
Tingling, 
Numbness 1 5.6 10 55.6 1 11.1 9 100.0 2 5.1 32 82.0 
Vertigo 12 66.7 1 11.1 7 77 .8 30 76.9 
Sexual Appe-
tite De-
creasedb 1 5.6 -- ---- 6 15.4 
Painful 
Vagina b 3 16.7 5 12.8 
Note. a Percentages based on n of group; Symptoms not on 
ist questionnaire. 
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Actual case numbers, as well as percentages for each group 
are included in Table 5 to ease comparisons between groups 
of unequal numbers. Group sizes varied. The premenopause 
group had 18 members, the menopause group 9 and the 
postmenopause group contained 39 members. Across all 
menopausal groups, the trend for the checklist symptoms 
frequencies to be greater than the corresponding open-
ended frequencies continued. 
Figure 5 is a graphic representation of the data 
presented in Table 5. It can be seen that the open-ended 
frequencies are less than the checklist frequencies across 
the board. For the open-ended frequencies, there are no 
real differences between the menopause groups. 
The checklist frequencies are more easily dis-
tinguished. The premenopause group has fewer responses 
than the menopause group. The postmenopause group had 
fewer positive responses than the menopause group. The 
menopause group had almost 100% positive responses for the 
checklist symptoms. 
Caution must be exercised in drawing conclusions from 
the above observations since the number of women in each 
group differs widely. Only a few differing responses 
could shift the data significantly. 
Research Question Four 
The fourth research question stated: 
Will women who list the same symptom(s) in the 
Hot Flash 
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Figure 5. Most frequently reported symptoms in menopausal 
groups (~ = 66). 
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open-ended questionnaire and the checklist rate 
the severity of the symptom(s) equally? 
The data in Figure 6 consist of paired data from the open-
ended and checklist questionnaires. If the symptom was 
present on both questionnaires, the severities were 
plotted. For example, if the symptom of hot flash was 
found on both the open-ended and checklist questionnaires 
with severity ratings of 3 and 1 respectively, they were 
plotted on the figure as 1-X (horizontal), 3-Y (vertical). 
The X-axis is the severity rating for the checklist and 
the Y-axis is the severity rating for the open-ended 
questionnaire. There were a total of 847 symptoms 
reported from both the open-ended and checklist question-
naires. Of these, there were a total of 139 matched pair 
symptoms found, or 32.8% of all symptoms reported. Of 
these, 52% (~ = 72) fell on the 1:1 (null hypothesis) line 
which represents equally rated symptoms. More women 
reported equal severity when the same symptoms appeared on 
both parts of the questionnaires than when the symptom 
appeared on one list only. For those who did not (48%, n 
= 67), the figure shows a definite trend toward answering 
the open-ended symptoms with a higher severity than the 
corresponding checklist symptoms. This is shown in the 
shaded area of the plot and represents 40% (n = 56) of the 
matched pairs. Only 8% (~ = 11) of the matched pairs 
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Another approach to this question was to consider 
each symptom individually when analyzing the paired data 
through the use of nonparametric statistics, specifically 
the Wilcoxon Matched-Pairs Signed-Test and the Signed-
Test. Each symptom was rated individually to determine if 
the severity rating between the open-ended and checklist 
questionnaire was statistically different. A significance 
level of .05 was chosen. If the test indicated a rating 
above the .05 value, the symptom was considered not to be 
answered significantly differently, that is, the severity 
ratings for all practical purposes were the same. 
Using the Wilcoxon Matched-Pairs Signed-Test, with 
appropriate degrees of freedom and a 2-tailed probability, 
the hot flash (.000), melancholia and depression (.016) 
and nervousness (.028) were all rated differently on the 
open-ended questionnaire than on the checklist. The 
Signed-Test produced the same results: hot flash (.000), 
melancholia and depression (.022), and nervousness (.031) 
(Table 6). 
In conclusion, when the same symptoms appeared on the 
open-ended and checklist portion of the questionnaire, 
they were rated the same severity for 52% (~ = 67) of the 
matched pairs. Of those that appeared only once, 40% (~ = 
56) of the severity ratings were rated higher on the open-
ended questionnnaire than on the checklist and only 8% (n 
= 11) of the severity ratings were rated higher on the 
Table 6 




















































Note. *Indicated a significant difference at the .05 
level (the null hypothesis that the question was answered 
the same on the open-ended and checklist questionnaire is 
rej ected) . 
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checklist than on the open-ended questionnaire. When each 
symptom was analyzed separately by use of nonparametric 
tests, the hot flash, melancholia and depression, and 
nervousness were the only symptoms with severity rankings 
statistically different between the open-ended and 
checklist questionnaires. 
Research Question Five 
The fifth research question stated: 
How many women have talked with their health 
care provider about menopause? 
Seventy-eight women answered this question. Nineteen of 
the 78 (24.3%) stated that they had not seen a health care 
provider about menopause. Sixty-six (75.6%) had seen a 
health care provider about menopause. For those who had 
seen a health care provider, 55 (93.2%) women commented on 
their satisfaction with the care they received. Ten 
(18.2%) were not satisfied with their care, 31 (52.4%) 
were satisfied, and 14 (25.5%) were uncertain. 
Table 7 displays the results for the women who 
provided information about the type of health care 
professional they saw. There were a total of 59 (75.6%) 
women who listed this information. 
In conclusion, the majority of women in this study 
had seen a health care provider about menopause. Physi-
cians were the health care provider consulted most often. 
Most women were satisfied with their care. 
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Table 7 
Type of Professional Seen for Menopausal 
Issues (!! = 59) 
Health Care Provider n % 
Physician 32 54.2 
Nurse 5 8.4 
Physician and Nurse 17 28.8 
Physician, Nurse and 
Herbalist 2 3.3 
other 3 5.1 
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Research Question Six 
Research question six stated: 
What percentage of women who consider themselves 
in the perimenopausal transition are taking 
hormone preparations or vasoactive drugs? 
Thirty-nine (exactly 50%) of the women in the study were 
taking hormone or vasoactive preparations. 
The frequency of use of these preparations varied, 
with some women taking more than one kind. Table 8 shows 
that the majority of women used estrogen preparations. 
Less than 18% (~ = 7) used vasoactive preparations for any 
reason. Users of progesterone drugs also accounted for 
less than 18% (~ = 7). Less than 8% used testosterone 
preparations. 
There was no attempt by the investigator to determine 
the specific reason why any particular woman took a 
specific preparation. If the participant took any hormone 
or vasoactive drug, she was included in the appropriate 
group, regardless of the specific condition requiring such 
treatment. 
Research Question Seven 
The seventh research question stated: 
What percentage of symptoms reported on the 
questionnaire will women report were also 
experienced before the perimenopausal transi-
tion? 
Thirty-three women in the study (43.0%) stated that they 
had had symptoms, usually associated with menopause, 
Table 8 
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Note. Some women took more than one preparation and will 
represented on the table more than once. 
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before their perimenopausal transition. Table 9 details 
these responses. Only those symptoms which were reported 
by at least 2 women are listed in the table (i.e., the 
list is not exhaustive). 
Hot flashes, melancholia and depression, and nervous-
ness were the most frequent symptoms that the women in 
this study described as having experienced before the 
perimenopausal transition. Each of the following symptoms 
reported by one respondent each, were: tingling or 
numbness, muscle or joint pains, skin changes, mood 
changes, dizziness, painful vagina, water retention, pain, 
vaginal discharge, cramps, and swelling of the legs. Six 
of the 11 symptoms which were included on the checklist 
questionnaire, also appear in Table 9 of the most frequent 
symptoms experienced in the period prior to the perimeno-
pausal transition. 
Research Question Eight 
Research question eight stated: 
How much will women state the perimenopausal 
transition has affected their daily lives? 
Women rated their overall impression of how much the 
perimenopausal transition had affected their daily lives 
on a 5-point scale. The results are presented in Figure 
7. The mean score was 2.42, the mode 2.0 and the median 
2.30, all falling on or near "a little change." 
Table 9 
Frequencies of Menopausal Symptoms Experienced 
Before the Perimenopausal Transition 
(n = 76) 
Symptom n % 
Hot Flash 8 10.3 
Melancholia, Depression 8 10.3 
Nervousness 6 7.7 
Changes in Menses 5 6.4 
Weakness, Fatigue 4 5.1 
Headaches 3 3.8 
Heart Palpitations 2 2.6 
Weight Change 2 2.6 
Irritability 2 2.6 
Anxiety, Stress 2 2.6 
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Figure 7. Self-rated effects of perimenopausal transition 
(n = 78). 
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Research Question Nine 
Research question nine stated: 
Will women who have certain demographic or 
lifestyle traits have less severe symptoms than 
women with those traits? 
An attempt was made to compare the women's overall rating 
of how much the perimenopausal transition had affected 
their lives, with certain demographic or lifestyle 
characteristics. For each variable considered, a criter-
ion was established, based upon standards found in the 
review of literature. Table 10 presents these criteria. 
The women were divided into the criteria presented in 
Table 10 by those who met the criteria and those who did 
not. The severity scores and the score on the 5-point 
scale were tallied for each group and divided by the 
number of cases in that particular group to give a mean 
severity score for each group. A student's t-test was 
performed with the appropriate degrees of freedom and a 2-
tailed probability determined. These data are presented 
in Table 11. 
It should be noted that the number of cases (~) for 
each group was different for each variable. Not all women 
in the study responded to each characteristic. The 
percentages given represent those who shared that charac-
teristic versus those who did not. 
As can be seen in Table 11, only 5 variables demon-
strated statistical significance at the .05 level. These 
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Table 10 




3. Gradual versus sudden 
menopause 
4. Adequate calcium 
5. Adequate protein 
6. Percentage of fat 
acceptable 
7. Calorie intake within 
acceptable range 
8. Have seen health care 
provider 
9. Have talked with some-
one about menopause 
10. Above high school edu-
tion 
11. Sexually active 
12. Taking no hormones or 
vasoactive drugs 




Exercise at least 30 minutes 
4 times/week 
Have a family income $20,000 
or above 
All reproductive organs 
intact 
24-hour recall must show at 
least 800 mg calcium/day 
24-hour recall must show > 
44 gm/day 
No more than 35% of the 
calories on 24-hour recall 
attributable to fat 
24-hour recall shows cal-
orie intake within accept-
able range for age, based on 
RDA 
Has seen a health care pro-
vider regarding menopause 
Has spoken with mother, 
sister, other relative, or 
friend concerning menopause 
Has attended some college 
Has stated she regularly 
participates in sexual 
relationship (reaches 
orgasm) 
Has taken no hormones or 
vasoactive drugs in the last 
5 years 
Has menstruated in last 12 
months. 
Has had no menses in last 12 
months, but LPM not more 
than 24 months previous 




Mean Severity Scores for Women for Each 
Modifying Variable 
Variable Total Missing Meets Mean Does Not Mean 2-tailed 
!!. Cases Criteria Severity Meet Severity Proba-
Criteria 
!!. % !!. % 
1. Exercise 52 26 28 53.8 2.75 24 46.2 1.02 .003* 
2. Income 66 12 51 77.3 2.37 15 22.7 2.47 .740 
3. Gradual versus 
sudden menopause 67 11 31 46.3 2.71 36 53.7 2.14 .012* 
4. Adequate calcium 59 19 11 18.6 2.78 48 81.4 2.40 .320 
5. Adequate protein 59 19 33 55.9 2.45 26 44.0 2.46 .980 
6. Percentage of 
fat in diet 
acceptable 59 19 33 55.9 2.45 26 44.0 2.46 .980 
7. Calorie intake 
with accept-
able range 59 19 13 22.0 2.71 46 77.9 2.50 .540 
8. Have seen a 
health care 
provider 76 2 52 76.0 2.58 19 25.0 1. 95 .016* 
9. Have talked with 
someone about 
menopause 75 3 63 84.0 2.54 12 16.0 1. 92 .050* 
10. Above high 
school education 77 1 60 77.9 2.42 17 22.1 2.41 .990 
11. Sexually active 76 2 59 77 .6 2.37 17 22.4 2.59 .440 
12. Taking no hor-
mones or vaso-
active drugs 78 0 30 50.0 1. 05 30 50.0 2.89 .000* 
13. Premenopausal 18 18 27.3 2.29 
Menopausal 9 12 9 13.6 2.91 
Postmenopausal 39 39 59.0 2.32 
Note. Percentages are expressed as a percentage of the n 
for that variable. *Statistically significant at the .05 
level. 
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seen a health care provider regarding the menopause, 
having taken hormones or vasoactive drugs and having 
talked with someone regarding menopause. 
The mean severity scores are of interest. The mean 
severity scores of groups HI and H2 fell as one might 
expect. Those women who did take hormones or vasoactive 
drugs had a higher mean severity score than those who did 
not. The mean severity scores for those who did not share 
the characteristics of the 4 significant variables 
(exercise, gradual versus sudden menopause, having seen a 
health care provider, or talked with someone about 
menopause) were all opposite of what might have been 
predicted. Those who shared the characteristics had 
higher mean severity scores than those who did not. 
Research Question Ten 
The tenth research question stated: 
What will be the reasons given by women that 
tell them they are in the perimenopausal 
transition? 
Women who answered that they were in the menopause were 
asked why they considered themselves experiencing meno-
pause. Sixteen (20.5%) of the women left this question 
blank while checking that they were in menopause. For the 
other 62 women, the responses were varied. Table 12 
contains these data. 
The most common response among those women with no 
answer was a question mark placed on the lines left for 
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Table 12 
Women's statements Concerning Why They Felt 
They Were in the Perimenopausal 
Transition (~ = 78) 
Responses n % 
No answer 16 20.5 
More than 1 reason 16 20.5 
No periods 15 19.2 
Surgery 12 15.4 
Symptoms, in general 8 10.3 
Hot flashes 5 6.4 
Taking hormones 3 3.8 
Stress 2 2.6 
Depression and mood 
swings 1 1.3 
this answer. The same number who did not answer this 
question provided more than one reason. These data are 
delineated in Table 13. 
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Among the single responses, no periods or menses was 
the most common symptom with 15 (19.2%) of the women in 
this group. Twelve (15.4%) women stated that after 
surgery they knew they were experiencing menopause. Other 
symptoms are presented in Table 13. 
The most popular response to this question was the 
combination of hot flash and no periods. The remainder of 
the responses were individualistic in nature. 
In conclusion, the data from this study, both from 
the open-ended and checklist portions of the question-
naire, were unique in many aspects. However, the results 
supported the findings from previous studies that many of 
the most common symptoms women report in the perimeno-
pausal transition were listed on the original BMI. 
Caution must be exercised in generalizing these observa-
tions to the entire population in the Boise Greater 
Metropolitan Arae or other parts of the state or country 




Women Who Had Multiple Reasons Why They Felt 
They Were in the Perimenopausal 
Transition (~ = 16) 











Hot flashes and no periods 
No periods and complete hysterec-
tomy 
Hot flashes and mood swings 
Hot flashes, no menses, and 
sleeping problems 
Hot flashes, night sweats, age, 
headaches and mood swings 
Menstrual irregularities and 
given hormones 
Age and surgery 
Symptoms in general and complete 
hysterectomy 
Ovaries removed and skin changes 
No periods, growing a beard and 
mood swings 
CHAPTER IV 
DISCUSSION OF FINDINGS 
This study explored the ways that women in a non-
clinical setting described their symptoms of menopause. 
The study was based on a framework of the perimenopausal 
period as one transition in women's lives. This is a 
complex process involving psychological, physiological, 
developmental/aging, and cultural issues. The relation-
ships between these issues are unclear as was evidenced in 
the review of literature. The study was intended to add 
to the body of knowledge about how this important period 
affects women's lives rather than to test a tool or 
technique of research. 
The research questions were answered in Chapter III. 
This chapter evaluates and interprets those results. It 
should be restated that the sample was unique in many ways 
and the findings cannot be applied to any other popula-
tion. The investigator's choice of women's clubs as a 
source of women in the perimenopausal period is the most 
likely source of the unique nature of the sample. It 
appears that women who are members of women's clubs in 
Boise, Idaho generally come from higher income and 
educational levels than are found in the general popula-
tion of that area. 
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The age range of the women in the sample was consis-
tent with that found in previous studies (Blatt et al., 
1953; Delaplaine et al., 1952; Flint & Garcia, 1979; 
Jaszman et al., 1969; Moore, 1981; Neugarten & Kraines, 
1965; Sharma & Saxena, 1981; Thompson et al., 1973; 
Walfisch et al., 1984). The age distribution of 37 to 72 
was also consistent with the findings of Gray (1976). 
That is, the number of women reaching menopause is greater 
at the lower end of the age range than at the higher end. 
Hence, the distribution was negatively skewed and the use 
of a mean alone is inappropriate; the median must always 
be included. The use of nonparametric statistics was 
appropriate in this study. 
The symptoms reported were not unlike the symptoms 
reported in other investigations. Of the 13 most common 
symptoms of the perimenopausal transition that women 
reported in this study, 11 were used on the 1953 Blatt 
Menopausal Index (Blatt et al., 1953). Only changes in 
menses and weight change were new in this study. It 
should be noted that 5 of the 6 most frequent symptoms on 
the open-ended questionnaire were also listed on the BMI 
(Blatt et al., 1953; Delaplaine et al., 1952; Flint & 
Garcia, 1979; Jaszman et al., 1969; Kupperman et al., 
1952; Moore, 1981; Neugarten & Kraines, 1965; Sharma & 
87 
Saxena, 1981; Thompson et al., 1973; Walfisch et al., 
1984). Further, these results are consistent with those 
of other researchers. The one exception was changes in 
menses. The content validity of the BMI is thus supported 
by the results of this study. Construct validity, always 
a difficult measure to define, was one of the aspects of 
research about menopause that was of interest to this 
investigator. This study demonstrated that an open-ended 
questionnaire, as opposed to a checklist of symptoms, 
yielded very different results without regard to whether 
the women were divided into groups or left as a whole. 
What was measured? When an open-ended question is asked, 
does the answer reflect the respondent's true impressions 
of her symptoms in perimenopause? If so, what do the more 
numerous symptoms reported by the same women in the 
checklist represent? 
This study was not designed to answer questions 
related to construct validity. It became an issue once 
the data were examined. There was no reason to assume 
that the same answers that appeared on an open-ended 
questionnaire would appear on the checklist questionnaire. 
The data, however, confirmed that throughout all groups 
(hormone groups, menopause groups and the same as a 
whole), more symptoms were acknowledged on the checklist 
than in open-ended questions, perhaps because of the 
stimulus presented. Further research is needed to 
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determine the reasons for this discrepancy. Until this 
issue is resolved, the question of construct validity will 
remain in relation to checklist questionnaires of symptoms 
of the menopause. 
Reliability of an instrument has not always been 
addressed in studies. It must be restated that this study 
was not one to test an instrument or a technique, but to 
describe the phenomena of the perimenopausal transition as 
experienced by women in a nonclinical setting. The BMI 
(Blatt et al., 1953) was adapted in the checklist portion 
of the questionnaire and the results confirmed that of 
previous studies (i.e., most of the more-frequently 
reported symptoms of the menopause) were contained in the 
index. This study does support the reliability of the 
index. 
A significant finding of the study was that the 
frequencies of symptoms reported divided the women using 
hormones and vasoactive drugs (HI) from those who did not 
use those substances (H2). Figure 3 demonstrates that in 
both the checklist and open-ended questions, the two 
groups did not cross over each other except in the changes 
in menses of the H2 (women who did not use hormones) 
group. The probability of this occurring was E < .0005, 
from a binomial table (Yamane, 1964). The investigator 
was not able to determine the precise timing of the use of 
hormones. At what point did women in the HI group begin 
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taking hormones? How severe were their symptoms? Did any 
of the women take hormones before physical symptoms were 
evident? As is often the case in research, analysis often 
leads to additional questions. Because the H2 group had 
more members in the premenopausal group than did the HI 
group, the increase in frequency in changes in menses was 
not too unusual. The premenopausal women are experiencing 
menstrual changes. The postmenopausal group experienced 
their last menstrual bleeding over 2 years before the 
study. It was not surprising that this latter group did 
not list changes in menses as frequently as the premeno-
pausal group. 
It appears from this study that the group of women 
who used hormones or vasoactive drugs were those who 
reported a greater severity of symptoms. The mean 
severity ratings for the hormone or vasoactive drug users 
(HI) was 2.89, while the nonhormone users had a mean 
severity rating of 1.95. Women in the HI group also 
reported more severe symptoms. The data support today's 
accepted medical practice of prescribing hormones only for 
those women who have severe or numerous symptoms. This 
has not always been the practice, however. The review of 
literature documents times when all women in the perimeno-
pausal period were given supplemental hormones. Current 
medical thought is that the risks of taking supplemental 
hormones must be weighed against the advantages (Thompson 
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et al., 1973). 
It appears that women who used hormones or vasoactive 
drugs in this study met the criterion of having numerous 
or more severe symptoms. That this group (Hl) reported 
more severe and more numerous symptoms while taking these 
chemicals is also of interest. It cannot be determined 
from the questionnaires how the women interpreted the 
questions as to whether they should list all the symptoms 
they had ever experienced during the menopause or just 
those they were currently experiencing. This would need 
to be clarified in a follow-up study. 
Women were not consistent in listing the same 
symptoms in both parts of the questionnaire. More 
symptoms were listed on the checklist than in the open-
ended questions. The reasons for this are not clear, but 
it is likely that the symptoms on the list reminded women 
of symptoms they had experienced before, but were not 
currently experiencing. It is only conjecture, however, 
because women were not asked to give reasons for the 
discrepancies. Only 32.8% (n = 139) of all symptoms were 
listed in both sections. 
Fifty-two percent (n = 72) of the women who listed 
the same symptoms in both sections of the questionnaire 
rated the severity of the symptoms the same. Those women 
who reported dissimilar symptoms also reported higher 
severity in the open-ended questions than on the check-
list. Did women who listed a symptom in the open-ended 
questionnaire feel that the symptom was severe, while 
those women who checked a symptom on a checklist did so 
even if the symptom was not severe? To answer these 
questions, a qualitative study would need to be designed 
to determine the women's perceptions through more inten-
sive interviews. 
When paired symptoms were examined symptom by 
symptom, only 3 had any statistical differences in 
severity ratings between Parts I and II of the question-
naire. These were hot flash, melancholia and depression 
and nervousness. As these are among the most common 
symptoms, it is not surprising that they vary more than 
those reported by very few respondents. 
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These 3 symptoms also appeared on the most frequent 
list of most researchers (Blatt et al., 1953; Delaplaine 
et al., 1952; Flint & Garcia, 1979; Jaszman et al., 1969; 
Kupperman et al., 1952; Moore, 1981; Neugarten & Kraines, 
1965; Sharma & Saxena, 1981; Thompson et al., 1973; 
Walfisch, 1984). With the exception of hot flash, these 
findings also correspond to those of Frey (1981) who 
described tired feelings as the most frequent symptoms of 
the perimenopausal period, followed by feeling blue or 
depressed. It is of interest that these 3 symptoms were 
also those that women reported that they had experienced 
most often before menopause. No explanation is offered 
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for these observations. Additional research is needed to 
uncover the etiology of these symptoms, and their unique-
ness to the reproductive period in a woman's life. 
The data that most surprised the investigator were 
those which described the modifying factors of the 
perimenopausal period. Conceptually, there were several 
factors that might influence how a woman may perceive her 
experience with menopause. Those factors included many 
habits that are felt to have an impact on general health, 
such as exercise, adequate nutrition, sexual activity, the 
gradual or sudden entrance into the perimenopausal period, 
and taking hormones or vasoactive drugs. Also considered 
were certain demographic qualities, namely, income and 
education. Seeing a health care provider about the 
menopause was also included. Each woman was placed in a 
group that either met the minimal standard for that factor 
or did not. 
The mean severity scores for both those who did, and 
those who did not meet the criteria for each factor were 
statistically different for 5 of the modifying factors 
including exercise, having seen a health care provider, 
gradual or sudden menopause, having talked with someone 
about the menopause and having taken hormones or vaso-
active drugs. Only the hormone groups had mean severity 
scores related to those factors that fell as expected. In 
this group, those women who took no hormones had smaller 
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mean severity scores than did those who took hormones. 
Because hormones are given to modify severe menopausal 
symptoms, it appeared logical that the scores fell as they 
did, provided the hormones were prescribed to relieve 
symptoms. 
On the other hand, the other 4 significant factors 
had mean severity scores that fell the opposite way. 
Those women who had not seen a health care provider or 
talked with a mother, sister, relative or friend about 
menopause had lower mean severity scores than those who 
had done so. This might be explained by the fact that 
those having a more disruptive time in the menopause would 
seek both professional and other advice to help them cope 
with their experiences. 
The last 2 significant factors are more difficult to 
interpret. Those women who did not exercise the recom-
mended amount of time had lower mean severity scores than 
those who did exercise. Those who had part of their 
reproductive organs removed and were felt to have had a 
sudden entrance into the menopause had a lower mean 
severity score than those who may have entered the 
perimenopausal transition more gradually. One could not 
conclude that removal of the reproductive organs and 
avoidance of exercise would lessen the discomfort of the 
perimenopausal transition. A cause and effect relation-
ship is not implied here. The data were checked re-
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peatedly to ascertain if an error in coding or data 
analysis had occurred. It had not. Among the logical 
explanations is that this was a small sample size with 
unique characteristics and that unknown factors do have an 
impact on these variables. Perhaps the women who exercise 
do so in an attempt to improve overall health to assist 
them in coping with a difficult perimenopausal transition. 
Some authors have suggested that women who have more 
adipose tissue than normal have less severe symptoms 
(Reitz, 1977). More women who had had their reproductive 
organs removed were taking hormones than were not. This 
could account for the lower mean severity scores. The 
women were not asked about the length of taking hormones. 
Time may have been a confounding variable influencing 
perception of symptom severity. 
When women were asked to rate their overall impres-
sions of how much they felt the perimenopausal transition 
had affected their lives on a 5-point scale, the majority 
stated they had experienced from very little change to 
definitely some change. Few selected the choices of no 
change, a lot of change, extensive change or unknown. 
This was consistent with the findings of Frey (1981) whose 
sample also showed very little effect upon women's lives 
of the perimenopausal transition. 
The response to the question, "Why do you feel you 
are in the menopause?" was varied. Over 20% of the women 
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left the question blank. About 20% gave the operational 
definition of no menses, less than 20% traced their 
menopause to surgery, and 20% gave more than one reason. 
Even smaller percentages responded with general symptoms, 
hot flashes, or hot flashes and no periods. There were 
many other individualized responses. This led the 
investigator to conclude that among this group of women, 
there was no universal Single factor definition of 
menopause. 
In conclusion, the majority of the data in this study 
were in consensus with that described by previous re-
searchers in this area. One area of new information was 
the marked difference in symptom reporting between an 
open-ended questionnaire and a checklist of symptoms. 
This is probably one effect of the technique. However, 
the distinct differences between the hormone and vasoac-
tive drug users and those who did not use these chemicals 
was marked. Further, the need for continued research to 
discern the factors which modify the menopause was also 
demonstrated. The drawbacks of previous studies were 
repeated in this study with regard to use of a checklist. 
The question of whether a checklist of symptoms suggests 
symptoms to women who may not otherwise have complained of 
them also warrants further study. 
CHAPTER V 
SUMMARY AND IMPLICATIONS 
FOR NURSING 
This study was a cross-sectional descriptive investi-
gation designed to investigate and describe the symptoms 
reported by women in the perimenopausal transition. The 
majority of the women in the study filled out the ques-
tionnaire at a meeting of their women's club to which the 
investigator was invited. Seventy-eight of the 205 women 
who filled out the questionnaire stated that they were 
experiencing menopause, and thus qualified for inclusion 
in the data analysis of the study. 
The women filled out a 2-part questionnaire concern-
ing their experiences with menopause. The first part of 
the questionnaire contained an open-ended question asking 
them to list any symptoms they might have had that they 
attributed to menopause. This part of the questionnaire 
was collected, and then a second portion was distributed 
that contained a checklist of menopausal symptoms which 
had been adapted from the BMI (Blatt et al., 1953). Women 
were asked to rate the severity of their symptoms on both 
parts of the questionnaire. A follow-up phone call was 
made to a majority of women in the study so that they 
could respond to questions regarding nutrition inad-
vertently left off their questionnaires. 
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It was not known what effect this omission had on the 
study. These questions were presented orally rather than 
in written form which might have affected the way the 
women answered the questions. Not all women in the study 
were presented the opportunity to answer this question 
because all were not traceable via the telephone. Once 
the data were collected, they were coded and analyzed. 
The number of different symptoms listed in the open-ended 
questions was 45. These 45 symptoms reported in the first 
part of the questionnaire included those listed on the 
checklist. In fact, after analysis, the 6 most frequent 
symptoms on the open-ended questions were found on the 
checklist portion of the questionnaire, as well. 
Another finding of the study was that there was a 
wide divergence between how the women answered the open-
ended questions and how they replied to the checklist. 
This was evident both in number of symptoms (greater on 
the checklist) and severity of symptoms. It was also 
noted that the women who used hormones or vasoactive drugs 
were differentiated from those who did not. The number of 
symptoms reported was higher for those who used hormones 
or vasoactive drugs. Women who used hormones or vasoac-
tive drugs also rated their symptoms as more severe. 
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Demographic data and other descriptive factors were 
used to compare various lifestyle practices with women's 
perception of the impact the perimenopausal transition had 
on their lives. In general, it was found that lifestyle 
traits did not affect the women's perceptions of meno-
pause. 
Suggestions for Future Nursing 
Research 
There continues to be a need for further research 
with women in the perimenopausal transition. The sample 
of this study was unique in income and educational levels. 
A broader base of women in a nonclinical population would 
be desirable. 
It would also be beneficial to design a qualitative 
study to determine perceptions from women about the 
perimenopausal phenomena. After reading all the question-
naires, it was evident that women often interpreted the 
same question differently. This was also apparent during 
data collection. Although every attempt had been made 
when designing the questionnaire to word the questions 
clearly, there was some confusion, or at least difference 
of opinion, on some questions. A good example might be 
the question that asked for the date of the last menstrual 
period. At one club, 2 women engaged in a very vocal 
discussion of whether the question asked for the last 
normal menses or just the last period. They deferred to 
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the investigator for clarification. There was agreement 
from other women present that some had believed the 
question meant the last normal period, while others 
interpreted the question to mean the last bleeding of any 
kind. Question interpretation, combined with the women's 
inability to clearly recall certain events, could bring 
any results of the study into question. A longitudinal 
study of women in the perimenopausal transition would 
eliminate some of these concerns. 
It was shown that the women in the study did not have 
a universally-understood definition of menopause. This 
was a segment of more highly-educated women than the 
general population. There may be even more confusion 
among women with less formal education. More interaction 
with the investigator may prove to be beneficial in order 
to help women give a name to their experience, and thus 
facilitate adjustment to the transition. 
Among the variables to include in a future study 
would be marital status and parity. This investigator 
would recommend that some physical measurements including 
height, weight and pap smear be done in order to correlate 
physical characteristics with reported symptoms, severi-
ties and experiences. Specific methods that women use to 
cope with their symptoms would be an interesting avenue of 
research. A comparison of vaginal smears with reported 
severity of symptoms would be useful because both an 
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objective and subjective view of the problem would provide 
a more complete picture. 
This investigator would recommend a pretest/posttest 
design. A researcher might use a questionnaire similar to 
that employed in this study and ask the women to answer 
the questions; then give a presentation where the peri-
menopausal transition is explained and conceptualized for 
the group; then repeat the questionnaire as a posttest at 
a later date. This design was suggested to the investiga-
tor by the comments of many women in this study. After 
the presentation had been given, many women asked for 
their questionnaires back because they wanted to change, 
add or delete answers; however, the questionnaires were 
not returned to the women. 
This study dealt predominantly with symptoms of the 
perimenopausal transition. Another approach would be to 
ask women to describe what the "change of life," meno-
pause, or perimenopausal transition meant to them, without 
any reference to symptoms. Would all women in this 
culture define menopause in symptom terms? 
In conclusion, there are variables that need to be 
included in future studies. There are other approaches, 
other methods of research in this field. Because there is 
no comprehensive theory developed in this area, there is 
opportunity for much factor-identifying research. Nurses, 
as health care providers, as health educators and many as 
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women themselves, are certainly in a unique position to 
contribute to the body of knowledge in this area. 
Using the goal-directed model of Dickoff and James 
(1968), this study could be labeled a participant at the 
factor-isolating level of theory. That is, if the goal of 
an investigator were to determine what is normal during 
this period of most women's lives, this study would add 
yet another piece of information to that which must be 
gathered in order to move to the factor-relating level. 
The investigator believes that this study was a pilot test 
of ways in which to ask women experiencing this phase of 
their lives to describe the factors they feel are im-
portant. More research needs to be done directed toward 
the goal of describing the perimenopausal experience for a 
wide range of women. 
Implications for Nursing 
Practice 
Nurse researchers, as well as practicing nurses, 
should always be aware that the way one asks a question 
greatly influences the amount and kind of information that 
is obtained. The differences in number of symptoms listed 
in open-ended questions versus the number of symptoms 
listed in a checklist is an excellent example of this 
principle. 
This study added to the body of knowledge about 
menopause while highlighting the many different ways women 
view this important transitional period in their lives. 
It has long been accepted that health care teaching is 
within the scope of the practice of nursing. It would 
102 
appear that health care teaching in this population has 
been less than optimum. New programs could be established 
to meet this need. Not only community-based nurses should 
be involved in this effort, but those nurses working in 
schools and public institutions should be active partici-
pants. Acute care nurses would also need to incorporate 
important health care instructions in their interactions 
with women who are in this period of their lives. 
Roy (1976) stated that one of the universal needs of 
man (or woman in this case) is the need to know what is 
normal. In the review of literature, the investigator 
found no study claiming to delineate what was a normal 
experience for women in menopause. Many women who 
participated in this study thanked the investigator for 
the opportunity to talk with some knowledgeable person 
about menopause. In fact, for the researcher, almost as 
much information was obtained from talking informally with 
the subjects after the data collection than from the 
questionnaire itself. It is very difficult to quantify 
the amount and type of information gleaned in this manner. 
In general, it was apparent that women were not aware of 
what they might expect, physically or emotionally, during 
this important time of their lives. This lack of informa 
tion did add to the general uneasy feeling the women 
reported they felt during this period. 
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The state of knowledge about this transitional period 
is still in its early beginnings. One of the goals of 
nursing might be to add to the body of knowledge regarding 
the normal range of experiences that occur in the peri-
menopausal transition. 
More information is needed before true theory can be 
established. Until this occurs, nurses cannot ignore the 
needs women have to talk with someone about their exper-
iences at this time. Nurses can use the information 
gathered from this and other studies to aid their clients 
in understanding what other women have described as their 
experiences in the perimenopause. As nurses have his-
torically taught young women about needs and experiences 
at menarche, nurses cannot ignore the opposite end of the 
reproductive periods of women's lives. 
APPENDIX A 
LETTER TO CLUBS OR GROUPS 
Club Name 
Club Address 
Dear Madame President: 
7219 Swift Lane 
Boise, Idaho 83704 
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I am a graduate nursing student from the University 
of Utah. I am completing a thesis in the women's health 
field of the menopause. This thesis involves research in 
the Boise area. I need to contact as many women as 
possible between the ages of 40 and 55 inclusive to answer 
a questionnaire about their experiences during menopause. 
If your membership includes this age group and you 
feel they would be interested in participating, I would be 
anxious to hear from you. 
I am proposing, if convenient, to come to a meeting 
of your group, explain my project and administer a 
questionnaire that will take from 20 to 30 minutes to 
complete. After administration of the questionnaire, I 
will be available to answer questions about the question-
naire, my project and menopause in general. I would be 
glad to do a 45-minute presentation on menopause if that 
would meet your needs. 
I feel that the data from this study will add to what 
is already known about this important period in every 
woman's life. Each participant, it is hoped, will gain 
some insight or knowledge about menopuase from her 
participation in this study. 
I would appreciate hearing from you as soon as 
possible, as I need to adhere to a strict schedule to 
complete this project as planned. 
Sincerely, 






Data Sheets: Part 1 
1. Birthdate 






3. What is the highest level of your education? 
Less than 7th Grade 
Junior High School (9th Grade) 
Partial High School (lOth or 11th Grade) 
High School Graduate 
Partial College (at least 1 year) or Special 
ized Training 
Standard College or University Graduation 
Graduate Professional Training (Graduate 
Degree) 
4. Have you used oral contraceptives (the pill) in the 
last 5 years? If so, give name, number of months 
used and year(s) used. Example -- Ovral, 36 months, 
1981-1982. 
Contraceptive Length Used Year(s) Used 
I have not used contractives in the last 5 
years 
5. Estrogen, progesterone, or other hormone preparations 
used in the last 5 years. Length used (month or 
years). Please list dosage if known. Example--
Premarin Cream, 2 years, 1 applicator full each day. 
Hormone Length Used Dosage (if 
known 
I have used no hormone preparations in the last 
5 years. 





7. Do you consider yourself in the menopause? 
Yes No Unsure 
If Yes, why? 
B. Please list the first menopausal change you exper-
ienced: 
lOB 
What month and/or year did you experience this change 
(date) : 
I have experienced no menopausal change. 
PLEASE CONTINUE TO THE NEXT PAGE 
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9. (a) Please list all changes (if any) you attribute to 
the menopause in the numbered column to the left and 
(b) mark an "X" opposite each change in the scale 
column to indicate the severity of each change -- how 
much it interfered with your daily life (be sure to 
include the change you mentioned in question 8): 
___ ~hange Scale 
( a) 
(b) 






( i ) 
( j ) 
(k 
( 1 ) 
None Mild Medium Severe Extremely 
Disruptive 
-- --
I have experienced no menopausal change. 
10. Of all changes listed in question 9, which changes 
did you experience to any degree before menopause? 
( a ) 
---~------~-------------(c)~ __ ~~~ _____ ~ ______________ _ 
( e ) 
---~-----~-----.-----------( 9 ) 
(i)--~-·····-~----------~----------
(b) ___________________ __ 
(d) ____ ~ _____ ~ ____ . _______ ...... __ 




11. How many times have you obtained health care consul-
tation for the above symptoms? 
times 
12. Have you talked with your mother, sister, relative, 
or friend(s) about menstruation? 
Yes No 
13. Have you talked with your mother, sister, relative, 
or friend(s) about menopause? 
Yes No 
14. Have you talked with a health care professional about 
menstruation? 
Yes No 
15. Have you talked with a health care professional about 
menopause? 
Yes No 
If yes, indicate the health care professional (check 





16. If you sought help from a health care professional, 
were you satisfied with the information or services 
received? 
Yes No Unsure 
17. Are you seeing a health care professional for any 
chronic condition(s)? 
Yes No 
If Yes, please list that (those) condition(s): 
III 
18. List any medication(s) and the dosage -- including 
vitamins, minerals, and pain relievers (example: 
aspirin, 2 tablets per day), prescription and 
nonprescription drugs or additives (example: wheat 
germ -- 1 tsp. per day, bee pollen -- one capsule 
every day) you are currently taking: 
Medication Dosa e Medication Dos 
19. Please list any exercise you regularly do and number 






20. Do you regularly participate in a sexual relationship 
at this time (reach orgasm regularly)? 
Yes No 
---
21. Please place an "X" on the scale below describing how 
much you feel the perimenopausal transition has 




A little Definitely A lot of 
change some change 
change 




Thank you! Please return this part of the questionniare 




Data Sheet -- Part III 
Age Today 
1. Please check any of the symptoms you are now exper-
iencing below, and indicate on the scale following 
each, the severity of the symptom(s). Severity may 
be defined as how much the symptom interferes with 









( i ) 






















None Mild Medium Severe Extremely 
Disruptive 
I have experienced no symptoms. 
lCategories adapted from Blatt et al., 1953. 
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2. Which of the symptoms listed below did you experience 
before menopause (check only the ones you did 
experience): 
(a) Hot Flashes 
(b) Tingling or Numbness in Arms or Legs 
(c) Insomnia 
(d) Nervouness 
(e) Melancholia (depressed feelings) 
(f) Vertigo 
(g) Muscle or Joint Pain 
(h) Headaches 
(i) Heart Palpitations 
(j) Weakness or Fatigue 
(k) Skin Changes 
3. other symptoms not listed in question 1 may be listed 





(d) _____________ __ 
Scale 
None Mild Medium Severe Extremely 
Disruptive 
I am having no (other) symptoms. 
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4. What is your annual family income from all sources? 
( a) Below $10,000 
(b) $10,000 - $19,999 
(c) $20,000 - $29,999 
(d) $30,000 - $39,999 
( e ) $40,000 - $49,999 
( f) $50,000 - $59,999 
(g) $60,000 - $69,999 
(h) $70,000 or more 
5. How many years have you had menopausal changes? 
years. 
I have had no changes 








Do not know 
* * * * * * * * * 
Thank you very much!! Your participation is well appre-
ciated. Please return Part II to the investigator. 
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Was this a typical day for you? Yes No 
8. Where do you usually eat? 
At home most of the time 
Out most of the time 
Eat out as much as eat at home 
* * * * * * * * * * * 
Thank you very much!! Your participation is appreciated. 
Please return Part II to the investigator. 
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